Post on 23-Mar-2023
1
Bachelor of Pharmacy Program
(International Program)
New Program 2004
---------------------
1. Title of Curriculum
Bachelor of Pharmacy Program (International)
2. Title of Degree
Full Name : Bachelor of Pharmacy
Abbreviation Name : B. Pharm.
3. Responsible Organization
Faculty of Pharmacy, Silpakorn University
4. Philosophy and Objectives
Academic policy for pharmacy education is to produce graduates with well-round
scholastic activities, good morality and professional etiquette, and experiences in various
professional disciplines to efficiently serve the public and community. Originally,
Pharmaceutical discipline involves arts and sciences of seeking and manufacturing drugs or
drug dosage forms from both natural and synthetic materials. It also covers the knowledges of
drug distribution, prescription, drug used evaluation, as well as drug information provided to
patients and health care personnel. Trends and directions of Pharmaceutical discipline at
present and in the future involve more and more in the aspect of integrated, multidisciplinary
and interdisciplinary mode of operation. Pharmacy and Pharmaceutical Sciences would now
concern many other disciplinary areas that can be brought into relation such as Health Related
Economic Problems, Sciences & Technology, Social & Behavioural Sciences, Archaeology &
Anthropology, Environments and Management, and Natural Conservation & Restoration. In
addition, The contextual changes of Higher Education Reforms in Thailand as well as the
rapid growth and advancement in sciences and technology including industrial activities and
professional practices at global standardization will definitely challenge Thai Universities to
elaborate higher international – class quality. Faculty of Pharmacy, Silpakorn University
realizes the needs to develop and offer international management of Pharmaceutical
Education of global standard which will of course lead to marketable competitions at the eage
of global free trade and services.
2
The general objectives of this Program are:
1.1 To develop and heighten quality of higher education in Pharmacy to meet
international standards.
1.2 To produce qualified graduates who can professionally apply both knowledge and
practical skill in pharmacy to efficiently serve the market needs both outside and
inside Thailand.
1.3 To produce qualified graduates who can efficiently continue their graduate
program abroad.
5. Program Commencement
June 2005
6. Eligibility for Application
An applicant must possess :
6.1 A certificate of high school level or the equivalent.
6.2 Proficiency in English by passing the required score in English examination
prescribed by Faculty Board of Admission or possess minimum TOEFL score of
500 or IELTS score of 5.5 with the exemption of those who graduate from
international program. The TOEFL score report or IELTS score report used for
application must not exceed 2 year.
6.3 Clear record of good conduct.
Students in the program is eligible to transfer to a 6-year Doctor of Pharmacy
Program which will be offered in 3 areas of concentration. Additionally, they are
allowed to transfer to a special project of undergraduate program with the approval
of the Faculty Committee.
7. Admission Criteria
Undergraduate students for international program are admitted through a selection
examination and interview administered annually by the Faculty of Pharmacy, Silpakorn
University.
8. Academic System
8.1 The academic system is based on the semester-credit system. Each academic
year is divided into two semesters. Each semester consists of a mininum of fifteen weeks. In
addition, 8 week courses may be offered during summer recess depending on availability of
resources.
3
8.2 Credit points units are counted and calculated as follow:
8.2.1 Lecture courses : 1 credit is equivalent to one hour per week
8.2.2 Practical courses : 1 credit is equivalent to 2-3 hours per week
8.2.3 Internship or Professional practice : 1 credits is equivalent to a minimum
of 45 hours per semester
8.2.4 Senior project : 1 credit is equivalent to a minimum of 45 hours per
semester
8.2.5 The amount of credits is calculated by using the assumption of the
course duration : lecture courses(l), practical courses(p) and self study
(s) divided by three.
The amount of credits = l+p+s
3
8.3 The language media for instruction in this program is English.
9. Study Duration
Students may complete the program within five years, but not exceeding ten years.
10. Enrollment
Full-time students must enroll for at least 12 credits but not exceeding 22 credits in each
semester. Enrolling for the summer session must not exceed 9 credits.
11. Grading System
11.1 Grading system for course work is A,B+,B,C+,C,D+,D,F and S/U. The overall
scholastic performance of a student is averaged and expressed in a semester as
a Grade-Point Average (GPA) and annually as a Cumulative Grade-Point
Average (cum.GPA)
11.2 Criteria for Graduation
To graduate, a student must:
11.2.1 pass all the required courses and receive total credits as stated in the
curriculum within ten years.
11.2.2 maintain cumulative GPA of at least 2.00 for the whole curriculum.
11.2.3 maintain cumulative GPA of at least 2.00 for pharmacy courses for the
bachelor degree level.
11.2.4 pass the professional practice courses of at least 500 practicing hours
with satisfaction and pass the senior project of not less than 45 working
hours.
4
12. Faculty Staff
Staff at the Faculty of Pharmacy will be responsible for teaching and managing the
program, give academic advice to students, and supervise for the senior project. The names of
the staff are listed in Appendix A.
13. Projected Enrollment
Student Status/year 2005 2006 2007 2008 2009
New students 60 60 60 60 60
2nd year students - 60 60 60 60
3rd year students - - 60 60 60
4th year students - - - 60 60
5th year students - - - - 60
Total 60 120 180 240 300
Estimated graduates - - - - 60
14. Facilities
14.1 Administration office and classrooms are located mainly in the building of the
Faculty of Pharmacy, Silpakorn University.
14.2 Other classrooms are located in many faculties in Silpakorn University which offer
courses listed in this curriculum.
14.3 Hospitals, Health Service Institutes, Manufacturing and other related organizations
of both public and private sections, both inside and outside Thailand, are
available for professional practice.
14.4 Computer labs at Faculty of Pharmacy and University Computer center are open
to student access.
14.5 The Faculty of Pharmacy - owned databases as well as Web CT courses
management and tutorial system are open for student access.
15. Library
Books, magazines, computers, and other resources related to the program are
accessible from the Faculty of Pharmacy's Reference Room "Prachote Plengvidhya" and
University's Central Library at Sanamchandra Palace Campus.
Items Quantities
15.1 Books : Thai language 2,165 titles
Foreign language 2,870 titles
15.2 Journals :Thai language 30 titles
Foreign language 60 titles
5
Databases such as Science Direct, Applied Science & Technology, Full text
General Science Abstracts, CAB Abstract, Medline, Dissertation Abstract Online and other
pharmacy and related databases of at least 1,482 Gigabytes are also available. In addition,
the Faculty of Pharmacy, Silpakorn University will improve the databases to 10 Terabytes
within 2007.
16. Budget
The estimated cost per each student of the program is 102,765 Baht / year.
17. Curriculum
17.1 A minimum of 188 accumulate credits are required.
17.2 Curriculum Structure
17.2.1 General Education Courses (minimum) 30 credits.
17.2.2 Specialization Courses (minimum) 152 credits.
Fundamental Courses in Sciences 30 credits.
Pharmacy Core Courses (minimum) 122 credits.
17.2.3 Free Electives (minimum) 6 credits.
17.3 Course Details
1. General Education Courses (minimum) 30 credits.
1.1 Compulsory Courses 20 credits.
Students have to enroll the following courses or other equivalent courses
as approved by the Faculty Committee.
- Languages 9 credits.
080 176 Language and Communication 3(3-0-6)
550 155 English for Pharmacy Students I 3(2-2-5)
550 158 English for Pharmacy Students II 3(2-2-5)
- Humanities 4 credits.
080 122 Professional Ethics 2(2-0-4)
550 153 Introductory Pharmaceutical Design 2(1-3-2)
- Social Sciences 2 credits.
080 144 Principles of Research 2(2-0-4)
- Mathematics and Basic Sciences 5 credits.
511 103 Mathematics for Biological Sciences Students 3(3-0-6)
563 251 Basic Public Health 2(2-0-4)
6
1.2 Compulsory Electives : students must choose one any foreign language
offered by the University of not less than 6 credits and must be two consecutive courses
of 6 credits.
080 179 Basic French I 3(2-2-5)
080 180 Basic French II 3(2-2-5)
080 183 Basic German I 3(2-2-5)
080 184 Basic German II 3(2-2-5)
080 187 Basic Chinese I 3(2-2-5)
080 188 Basic Chinese II 3(2-2-5)
080 189 Basic Japanese I 3(2-2-5)
080 190 Basic Japanese II 3(2-2-5)
1.3 Electives (minimum) 4 credits
Student chooses 4 credits from the following courses or other equivalent
courses as approved by the Faculty Committee:
080 101 Man and Creativity 3(3-0-6)
080 107 Music Appreciation 2(2-0-4)
080 114 Art Appreciation 2(2-0-4)
080 117 Literary Appreciation 2(2-0-4)
080 119 Eastern Civilization 2(2-0-4)
080 126 Man and His Environment 3(3-0-6)
080 127 Introduction to Psychology 2(2-0-4)
080 133 Economics in Everyday Life 2(2-0-4)
080 135 Law and Society 2(2-0-4)
415 151 Southeast Asian World 2(2-0-4)
449 106 Conservation of Resources and Environment 2(2-0-4)
550 101 Basic Computer Applications in Pharmaceutical Sciences 2(1-3-2)
550 156 Introduction to Pharmaceutical Dosage Forms and
Technology 2(2-0-4)
* 554 101 Herbal Medicine 3(3-0-6)
* 554 102 Drug Education 3(3-0-6)
* 554 103 Man and Toxic Substances 3(3-0-6)
* 554 104 Food for Health 3(3-0-6)
565 151 Drug Knowledges 3(3-0-6)
566 101 Pharmaceutical Botany 2(1-3-2)
7
Remarks * Courses offered for non-pharmacy students. Pharmacy students may enroll
these courses under special condition and with consent of the Faculty.
2. Specialization Courses (minimum) 152 credits
2.1 Basic Fundamental in Sciences 30 credits
Students have to enroll the following courses or other equivalent courses as
approved by the Faculty Committee:
2.1.1 Mathematics and Statistics 3 credits
515 203 Statistics for Pharmacy Students 3(2-2-5)
2.1.2 Basic Sciences 27 credits
512 101 General Biology I 3(3-0-6)
512 102 General Biology II 3(3-0-6)
512 103 General Biology Laboratory I 1(0-3-0)
512 104 General Biology Laboratory II 1(0-3-0)
513 101 General Chemistry I 3(3-0-6)
513 102 General Chemistry II 3(3-0-6)
513 220 Physical Chemistry 3(3-0-6)
513 250 Organic Chemistry 3(3-0-6)
514 101 General Physics I 3(3-0-6)
514 102 General Physics II 3(3-0-6)
514 105 General Physics Laboratory for Pharmacy Students 1(0-3-0)
2.2 Pharmacy Core Courses (minimum) 122 credits
2.2.1 Health Sciences 29 credits
561 101 Biopharmacy I 2(2-0-4)
561 102 Biopharmacy II 2(2-0-4)
561 103 Basic Molecular Biology for Pharmacists 1(1-0-2)
561 131 Biopharmacy Laboratory I 1(0-3-0)
561 201 Biopharmacy III 3(3-0-6)
561 202 Biopharmacy IV 2(2-0-4)
561 203 Biopharmacy V 4(4-0-8)
561 231 Biopharmacy Laboratory III 1(0-3-0)
561 232 Biopharmacy Laboratory IV 1(0-3-0)
561 233 Biopharmacy Laboratory V 1(0-3-0)
565 241 Pharmacology I 3(3-0-6)
565 242 Pharmacology II 4(4-0-8)
8
565 243 Toxicology 2(2-0-4)
565 261 Pharmacology Laboratory I 1(0-3-0)
565 263 Toxicology Laboratory 1(0-3-0)
2.2.2 Professional Courses (minimum) 93 credits
- Professional Compulsory Courses 82 credits
550 102 Basic Pharmaceutical Laboratory 1(0-3-0)
550 151 Pharmacy Orientation 1(1-0-2)
550 251 Professional Practice I 1(0-3-0)
550 332 Pharmacy Law 1(1-0-2)
550 351 Professional Practice II 3(0-9-0)
550 352 Professional Practice III 5(0-15-0)
550 359 Computer in Pharmacy 3(2-3-4)
550 361 Seminar in Pharmaceutical Sciences 1(0-3-0)
550 366 Pharmacotherapeutics II 4(3-3-6)
550 367 Pharmacotherapeutics III 4(3-3-6)
550 399 Senior Project 1(0-3-0)
561 211 Biological Products 2(2-0-4)
562 321 Biopharmaceutics and Pharmacokinetics 3(3-0-6)
562 361 Pharmacy Practice 4(3-3-6)
563 254 Basic Pharmacy Administrations I 2(2-0-4)
563 255 Basic Pharmacy Administrations II 2(1-3-2)
564 111 Pharmaceutical Chemistry I 1(1-0-2)
564 121 Pharmaceutical Chemistry Laboratory I 1(0-3-0)
564 131 Pharmaceutical Quality Control I 3(3-0-6)
564 132 Pharmaceutical Quality Control Laboratory I 2(0-6-0)
564 211 Pharmaceutical Chemistry II 3(3-0-6)
564 212 Pharmaceutical Chemistry III 4(4-0-8)
564 231 Pharmaceutical Quality Control II 3(3-0-6)
564 233 Pharmaceutical Quality Control Laboratory II 1(0-3-0)
565 352 Pharmacotherapeutics I 3(3-0-6)
566 111 Pharmacognosy I 3(3-0-6)
566 121 Pharmacognosy Laboratory I 1(0-3-0)
566 211 Pharmacognosy II 2(2-0-4)
566 221 Pharmacognosy Laboratory II 1(0-3-0)
9
567 221 Pharmaceutical Technology I 2(2-0-4)
567 222 Pharmaceutical Technology II 3(3-0-6)
567 223 Pharmaceutical Technology III 3(3-0-6)
567 224 Pharmaceutical Technology IV 2(2-0-4)
567 225 Pharmaceutical Technology V 2(2-0-4)
567 261 Pharmaceutical Technology Laboratory I 1(0-3-0)
567 262 Pharmaceutical Technology Laboratory II 1(0-3-0)
567 263 Pharmaceutical Technology Laboratory III 1(0-3-0)
567 264 Pharmaceutical Technology Laboratory IV 1(0-3-0)
- Professional Elective Courses (minimum) 11 credits
Professional elective courses are categorized into 3 areas of concentration. Students
must choose 11 credits from one of any areas of concentration. Student who wants to enroll
for courses outside the chosen area of concentration should ask for permission from the
Faculty.
: Professional Elective Courses in Pharmaceutical Care
550 202 Nutrition and Nutritional Therapy 2(2-0-4)
550 207 Nutrition and Drug Interactions 2(2-0-4)
550 208 Nutritional Assessment 2(1-3-2)
550 209 Minerals and Vitamins in Nutrition 2(1-3-2)
550 211 Medical Equipment and Accessories 2(1-3-2)
550 212 Intravenous Admixture 2(1-3-2)
550 213 Radiopharmaceuticals 2(2-0-4)
550 214 Hospital Pharmacy 4(3-3-6)
550 215 Pharmacoepidemiology 3(2-3-4)
550 216 Pharmacoeconomics 2(2-0-4)
550 217 Environmental Clinical Toxicology 3(1-6-2)
550 221 Applied Pharmacognosy 2(2-0-4)
550 311 Drug Information in Pharmaceutical Care 3(2-3-4)
550 312 Current Topics in Pharmacy Practice 4(3-3-6)
550 315 Advanced Biopharmaceutics 3(2-3-4)
550 316 Clinical Pharmacokinetics 2(1-3-2)
550 317 Evidence Base in Pharmaceutical Care 3(2-3-4)
550 318 Outcomes Drug Assessment 3(2-3-4)
10
550 319 Drug Assessment 2(1-3-2)
550 320 Drug Use Evaluation I 3(2-3-4)
550 321 Drug Use Evaluation II 3(2-3-4)
550 324 Evaluation of Drug Action 2(2-0-4)
550 330 Clinical Pharmacology 3(2-3-4)
550 333 Evidence Base Phytotherapy 2(2-0-4)
550 334 Current Therapy in Pharmaceutical Care 4(3-3-6)
550 365 Advanced Clinical Pharmacy 4(3-3-6)
550 369 Special Problems in Pharmaceutical Care 2(1-3-2)
: Professional Elective Courses in Pharmaceutical Sciences
550 201 Safety of Foods and Drinking Water 3(1-6-2)
550 203 Pharmaceutical Quality Control IV 2(2-0-4)
550 204 Pharmaceutical Quality Control Laboratory IV 1(0-3-0)
550 205 Drug Biotransformation I 3(3-0-6)
550 206 Drug Biotransformation II 3(3-0-6)
550 210 Immunopathology 3(3-0-6)
550 218 Veterinary Pharmaceutical Products 3(2-3-4)
550 219 Environmental Toxicology 4(3-3-6)
550 220 New Drugs and Current Drugs 2(2-0-4)
550 222 Molecular Biotechnology for Pharmacists 3(3-0-6)
550 223 Pharmaceutical Quality Control III 4(2-6-4)
550 224 Pharmaceutical Quality Control of Food and Cosmetics 4(3-3-6)
550 225 Biomedical Analysis 4(3-3-6)
550 226 Pharmaceutical Chemistry Analysis of Dietotherapeutics 3(2-3-4)
550 227 Mutation Evaluation of Drugs and Environmental Toxic
Substances 3(1-6-2)
550 228 Basic Cellular and Molecular Pharmacology 3(3-0-6)
550 229 Experimental Pharmacology 2(0-6-0)
550 230 Separation Technique in Pharmaceutical Sciences 3(2-3-4)
550 231 Indigenous Medicines 4(3-3-6)
550 232 Agropharmaceutical Sciences 4(3-3-6)
550 233 Biotechnology of Medicinal Plants 3(2-3-4)
550 234 Novel Drug Delivery System 2(2-0-4)
550 235 Cosmeticology 4(2-6-4)
11
550 236 Manufacturing Management 4(3-3-6)
550 237 Quality Control and Quality Assurance Systems 4(3-3-6)
550 238 Tablet Coating 3(2-3-4)
550 239 Introductory Polymer Sciences in Pharmacy 2(2-0-4)
550 240 Industrial Hygiene 4(3-3-6)
550 301 Special Problems in Pharmaceutical Sciences 3(2-3-4)
550 306 Current Topics in Pharmaceutical Sciences 2(2-0-4)
550 307 Advanced Biopharmacy 3(3-0-6)
550 322 Pharmaceutical Synthesis 3(2-3-4)
550 325 Pharmacology of Neuropsychoactive Drugs 4(3-3-6)
550 326 Pharmacology of Cardiovascular Drugs 3(2-3-4)
550 327 Pharmacology of Gastrointestinal Drugs 3(2-3-4)
550 331 Pharmaceutical Packagings 2(2-0-4)
550 338 Principle of Medicinal Chemistry 3(3-0-6)
550 340 Drug Designs 4(3-3-6)
550 343 Advanced Pharmacology and Toxicology 3(3-0-6)
550 347 Research and Development in Medicinal Plants 3(2-3-4)
550 349 Pharmaceutical Formulation and Development 4(2-6-4)
550 355 Pharmaceutical Biotechnology 3(2-3-4)
550 356 Pharmacogenomics 2(2-0-4)
550 360 Computerized Applications in Pharmaceutical Sciences 3(1-6-2)
550 370 Research and Development of Pharmaceutical Products 2(2-0-4)
550 371 Management in Pharmaceutical Sciences 2(2-0-4)
550 372 Quality Assurance in Pharmaceutical Sciences 3(3-0-6)
: Professional Elective Courses in Pharmaceutical Informatics
550 215 Pharmacoepidemiology 3(2-3-4)
550 216 Pharmacoeconomics 2(2-0-4)
550 241 Community Pharmacy 3(2-3-4)
550 242 Public Health Pharmacy 3(2-3-4)
550 243 Pharmacists and Rural Health Care 4(2-6-4)
550 244 Drug Marketing and Detailing 3(2-3-4)
550 360 Computerized Applications in Pharmaceutical Sciences 3(1-6-2)
550 362 Drug Information Services 3(2-3-4)
550 363 Consumer Protection in Foods and Drugs 3(2-3-4)
550 364 Special Problems in Community Pharmacy 3(2-3-4)
12
550 368 Public Health Administration 3(2-3-4)
550 373 Communication and Health 3(1-6-2)
550 374 Strategy in Pharmacy Administration 3(2-3-4)
550 375 Pharmaceutical Information Management 3(2-3-4)
3. Free Electives (minimum) 6 credits.
Students may choose from courses offered by the University or Faculty, both in
side and outside Thailand. If student chooses courses from professional elective courses as
free electives, grades earned from these courses will be calculated for cum. GPA of pharmacy
courses according to the graduation criteria.
Students may replace the courses in this curriculum with another courses offered
within the University, or those offered by other University subject to approval by the Faculty
Committee.
17.4 Status of the undergraduate students.
Status of an undergraduate student will be classified into 5 categories according to his
or her credit earned from this curriculum ;
- Undergraduate student possessing credit earned less than 32 is equivalent to a
first – year - student.
- Undergraduate student possessing credit earned from 32 to 63 is equivalent to
a second – year – student.
- Undergraduate student possessing credit earned from 64 to 95 is equivalent to
a third – year – student.
- Undergraduate student possessing credit earned from 96 to 127 is equivalent
to a forth – year – student or senior standing.
- Undergraduate student possessing credit earned more than 127 is equivalent
to a fifth – year – student or senior standing.
13
17.5 Study plan
Year 1, First Semester
Course Number Course Title Credits
��� ��� Language and Communication �(�-�-�)
��� … Foreign Language I �(�-�-�)
��� ��� Mathematics for Biological Sciences Students �(�-�-�)
��� ��� General Biology I �(�-�-�)
��� ��� General Biology Laboratory I �(�-�-�)
��� ��� General Chemistry I �(�-�-�)
��( ��� General Physics I �(�-�-�)
��� ��� Pharmacy Orientation �(�-�-�)
Total ��
Year 1, Second Semester
Course Number Course Title Credits
��� … Foreign Language II �(�-�-�)
��� ��� General Biology II �(�-�-�)
��� ��( General Biology Laboratory II �(�-�-�)
��� ��� General Chemistry II �(�-�-�)
��( ��� General Physics II �(�-�-�)
��( ��� General Physics Laboratory for Pharmacy
Students
�(�-�-�)
��� ��� Statistics for Pharmacy Students �(�-�-�)
��� ��� Basic Pharmaceutical Laboratory �(�-�-�)
��� ��� Basic Public Health �(�-�-()
Total ��
14
Year 2, First Semester
Course Number Course Title Credits
��� ��� Physical Chemistry �(�-�-�)
��� ��� Organic Chemistry �(�-�-�)
��� ��� Introductory Pharmaceutical Design �(�-�-�)
��� ��� English for Pharmacy Students I �(�-�-�)
��� ��� Biopharmacy I �(�-�-()
��� ��� Biopharmacy Laboratory I �(�-�-�)
��( ��� Pharmaceutical Chemistry I �(�-�-�)
��( ��� Pharmaceutical Chemistry Laboratory I �(�-�-�)
… … Electives in General Education Courses �
Total ��
Year 2, Second Semester
Course Number Course Title Credits
��� ��� English for Pharmacy Students II �(�-�-�)
��� ��� Biopharmacy II �(�-�-()
��� ��� Biopharmacy III �(�-�-�)
��� ��� Biopharmacy Laboratory III �(�-�-�)
��� ��( Basic Pharmacy Administration I �(�-�-()
��( ��� Pharmaceutical Quality Control I �(�-�-�)
��( ��� Pharmaceutical Quality Control Laboratory I �(�-�-�)
��� ��� Pharmaceutical Technology I �(�-�-()
��� ��� Pharmaceutical Technology Laboratory I �(�-�-�)
… … Electives in General Education Courses �
Total ��
15
Year 3, First Semester
Course Number Course Title Credits
��� ��� Biopharmacy IV �(�-�-()
��� ��� Basic Molecular Biology for Pharmacists �(�-�-�)
��� ��� Biopharmacy Laboratory IV �(�-�-�)
��( ��� Pharmaceutical Quality Control II �(�-�-�)
��( ��� Pharmaceutical Quality Control Laboratory II �(�-�-�)
��� �(� Pharmacology I �(�-�-�)
��� ��� Pharmacology Laboratory I �(�-�-�)
��� ��� Pharmacognosy I �(�-�-�)
��� ��� Pharmacognosy Laboratory I �(�-�-�)
��� ��� Pharmaceutical Technology II �(�-�-�)
��� ��� Pharmaceutical Technology Laboratory II �(�-�-�)
Total ��
Year 3, Second Semester
Course Number Course Title Credits
��� ��� Biopharmacy V (((-�-�)
��� ��� Biopharmacy Laboratory V �(�-�-�)
��� ��� Biopharmaceutics and Pharmacokinetics �(�-�-�)
��� �(� Pharmacology II (((-�-�)
��� ��� Pharmacognosy II �(�-�-()
��� ��� Pharmacognosy Laboratory II �(�-�-�)
��� ��� Pharmaceutical Technology III �(�-�-�)
��� ��� Pharmaceutical Technology Laboratory III �(�-�-�)
Total �4
16
Year 4, First Semester
Course Number Course Title Credits
��� ��� Professional Ethics �(�-�-()
��� �(( Principles of Research �(�-�-()
��� ��� Professional Practice I �(�-�-�)
��� ��� Pharmacy Law �(�-�-�)
��� ��� Biological Products �(�-�-()
��� ��� Pharmacy Practice ((�-�-�)
��( ��� Pharmaceutical Chemistry II �(�-�-�)
��� ��� Pharmacotherapeutics I �(�-�-�)
��� ��( Pharmaceutical Technology IV �(�-�-()
��� ��( Pharmaceutical Technology Laboratory IV �(�-�-�)
Total ��
Year 4, Second Semester
Course Number Course Title Credits
��� ��4 Computer in Pharmacy �(�-�-()
��� ��� Pharmacotherapeutics II ((�-�-�)
��� ��� Basic Pharmacy Administrations II �(�-�-�)
��( ��� Pharmaceutical Chemistry III (((-�-�)
��� �(� Toxicology �(�-�-()
��� ��� Toxicology Laboratory �(�-�-�)
��� ��� Pharmaceutical Technology V �(�-�-()
Professional Electives (
Total ��
17
Year 5, First Semester
Course Number Course Title Credits
��� ��� Professional Practice II �(�-4-�)
��� ��� Seminar in Pharmaceutical Sciences �(�-�-�)
��� ��� Pharmacotherapeutics III ((�-�-�)
��� �44 Senior Project �(�-�-�)
Professional Electives �
Free Electives �
Total ��
Year 5, Second Semester
Course Number Course Title Credits
��� ��� Professional Practice III �(�-��-�)
Total �
18
17.6 COURSE DESCRIPTION
17.6.1 General Education Courses
080 122 Professional Ethics 2(2-0-4)
Codes and oaths of professional ethics of various disciplines; laws, rules,
regulations and ethical criteria concerning practice and control, with emphasis
on privileges and responsibilities to professions and socials.
080 144 Principles of Research 2(2-0-4)
Conceptual aspects, definition and principles of research ; categorization,
differentiation and processes of performing research ; data collecting, valuating
and reporting of results.
080 176 Language and Communication 3(3-0-6)
A study of basic concept and principles of language communication: a
logical conception and rules of Thai language usage. Practice of the using of
words, idioms, and clauses, the writing of narration, description, explanation,
and discussion.
511 103 Mathematics for Biological Science Students 3(3-0-6)
Graphs of quadratic equations in two variables. Differentiation and
integration. Taylor and Macclaurin series. First – order differential equations.
System of simultaneous linear equations and their solution.
550 101 Basic Computer Applications in Pharmaceutical Sciences 2(1-3-2)
Basic principles of computer especially utilization of software in
pharmaceutical fields; including concepts of data presentation, reporting,
programming for application in pharmacy.
550 153 Introductory Pharmaceutical Design 2(1-3-2)
Appropriate design of pharmaceutical and medicinal packaging in
accordance with professional description and usages.
19
550 155 English for Pharmacy Students I 3(2-2-5)
Practicing skill in reading and speaking with emphasis on data or articles
in health sciences .
550 156 Introduction to Pharmaceutical Dosage Forms and Technology 2(2-0-4)
All pharmaceutical dosage forms including their definitions, classifications,
terminology, compositions, application in pharmacy and basic techniques of
preparation.
550 158 English for Pharmacy Students II 3(2-2-5)
Practicing skill in reading, writing, briefing and concluding, and
presenting, with emphasis on literatures, journal, text books, data or articles in
health sciences.
554 101 Herbal Medicines 3(3-0-6)
Plants and natural products concerning living and surviving of human life
with emphasis on medicinal, food survival and poisonous plants.
554 102 Drug Education 3(3-0-6)
General knowledges about drugs with emphasis on general properties,
sources, concepts, drug action, distribution, dosages, potency, toxicity,
categorization, rational uses, safety measure, household remedies, over – the –
counter drugs, drug abuses, laws and regulations, behavioural drug use
patterns in Thai society.
554 103 Man and Toxic Substances 3(3-0-6)
Fundamental knowledge of toxicity from chemicals, food and others
encountered in everyday life, first-aid treatments, relevant laws, prevention and
selection of the consuming products in order to safeguard consumers from
being intoxicated.
20
554 104 Food for Health 3(3-0-6)
Introduction to bodily need of food, compositions of food, food hygiene
and health, imbalance diets and diseases, eating patterns and health: with
special emphasis on prevention and treatment of the community nutritional
problems.
563 251 Basic Public Health 2(2-0-4)
Basic knowledges in medical demography, epidemiology, biostatistics,
family plannings, population problems, nutrition, mental health and hygiene,
ecological environments, and national health system.
565 151 Drug Knowledges 3(3-0-6)
Pharmacological concepts and origins of drugs and drugs actions,
classification and categorization, principles and conceptual aspects of drug
preparations from resources ; dosages, indications and rational uses: principles
and concepts of drug actions, potency, toxicity and safety measures, drugs
abuses, mechanisms of action, therapeutic values and indications of household
remedies.
566 101 Pharmaceutical Botany 2(1-3-2)
Classification and identification of medicinal plants of economic,
therapeutic and ecological potentials using chemical and biochemical properties,
emphasizing on medicinal plants of Thailand and neighboring countries.
17.6.2 Specialization Courses
17.6.2.1 Basic Fundamental in Sciences
515 203 Statistics for Pharmacy Students 3(2-2-5)
Basic knowledge of statistics and probability. Sampling techniques.
Estimation. Hypothesis testing. Simple regression and correlation. Testing of
nonparametric statistics. One-way and two-way analysis of variance. Basic
concepts of experimental designs.
21
512 101 General Biology I 3(3-0-6)
Prerequisite :
* 512 103 General Biology Laboratory I
* May be taken concurrently
Concepts on biology. Molecular basis of life. Cellular level of organization,
tissues and Organs. Genetics, gene manipulation and evolution. Animal
reproduction and development. Immune system. Human and ecosystem.
Adaptation and animal behavior. Plant technology. Microorganisms and
applications.
512 102 General Biology II 3(3-0-6)
Prerequisite :
* 512 104 General Biology Laboratory II
* may be taken concurrently
Biodiversity. Plant tissues and organs. Cellular respiration and
Photosynthesis in plant. Structures and functions of various systems and
organs of animals including regulatory mechanisms.
512 103 General Biology Laboratory I 1(0-3-0)
Prerequisite :
* 512 101 General Biology I
* may be taken concurrently
Laboratory work related to the contents in 512 101 General Biology I.
512 104 General Biology Laboratory II 1(0-3-0)
* 512 101 General Biology II
* may be taken concurrently
Laboratory work related to the contents in 512 102 General Biology II.
513 101 General Chemistry I 3(3-0-6)
Stoichiometry. Atomic structure and properties of the elements in the
periodic table. Chemical bonding. Gases. Solids. Thermodynamics.
513 102 General Chemistry II 3(3-0-6)
Prerequisite :
22
513 101 General Chemistry I
Liquids and solution. Chemical equilibrium and ionic equilibrium.
Electrochemistry. Chemical Kinetics. Introduction to organic chemistry.
513 220 Physical Chemistry 3(3-0-6)
Prerequisite :
(1)
511 102 Calculus II
513 102 General Chemistry II
or (2)
513 102 Mathematics for Biological Science Students
513 102 General Chemistry II
Thermodynamics of gas and solution. Chemical equilibrium and ionic
equilibrium. Electrolytic solution. Chemical kinetics. Macromolecules. Principles
of nuclear chemistry and biological applications. Electromagnetic radiation and
matters.
513 250 Organic Chemistry 3(3-0-6)
Prerequisite :
513 102 General Chemistry II
Chemistry of aliphatic compounds. Aromatic compounds and compounds
with polyfunctional groups. Carbohydrates. Amino acids. Proteins and liquids.
Introduction to ultraviolet and infrared spectroscopies.
514 101 General Physics I 3(3-0-6)
Mechanics of particles and rigid bodies. Properties of matter. Fluid
mechanics. Kinetic theory of gases. Thermodynamics. Vibrations and waves.
514 102 General Physics II 3(3-0-6)
Electricity. Introduction to electronics. Optics. Special theory of relativity
and quantum physics.
514 105 General Physics Laboratory for Pharmacy Students 1(0-3-0)
23
Prerequisite :
514 101 General Physics I
* 514 102 General Physics II
* may be taken concurrently
Experiments for pharmacy students related to the contents in 514 101
General Physics I and 514 102 General Physics II.
17.6.2.2 Pharmacy Core Courses
550 102 Basic Pharmaceutical Laboratory 1(0-3-0)
Basic pharmaceutical laboratory techniques in biopharmacy,
pharmaceutical technology, pharmaceutical chemistry and natural products.
550 151 Pharmacy Orientation 1(1-0-2)
An introductory course for pharmacy students about history of pharmacy,
professional ethics; structure of pharmaceutical curricula in Thailand; roles of
pharmacists in various areas of concentration, both in government and private
sectors; inter-relationship among professions in public health; pharmaceutical
literatures.
550 201 Safety of Foods and Drinking Water 3(1-6-2)
Pre-requisite : 561 203 Biopharmacy V
Useful components of food, contaminants in food and water, food
containers, quality control standards of food and water, related methods of
analysis, emphasizing consumer protection stated in related rules and
standards.
550 202 Nutrition and Nutritional therapy 2(2-0-4)
Pre-requisite : 561 202 Biopharmacy IV
Nutrients, daily needs and allowances, energy utilization and
conservation, appropriate and proper nutrition for patients suffering from cardiac
diseases, diabetis mellitus, obesity and others; malnutrition, preventives and
treatments.
24
550 203 Pharmaceutical Quality Control IV 2(2-0-4)
Pre-requisite : 561 203 Biopharmacy V
Quality control and assurance of pharmaceutical products utilizing
biological methods, emphasizing micro-bioassays of antibiotics, vitamins, and
others, determination of bioavailability, general toxic effects and sterility.
550 204 Pharmaceutical Quality Control Laboratory IV 1(0-3-0)
Pre-requisite : 550 203 Pharmaceutical Quality Control IV *
*can be co-requisite
Laboratory study of pharmaceutical quality control utilizing biological
methods, including micro-bioassays of antibiotics, vitamins, and others,
determination of bioavailability, general toxic effects and sterility.
550 205 Drug Biotransformation I 3(3-0-6)
Pre-requisite : 562 321 Biopharmaceutics & Pharmacokinetics
Transformation of drugs in the body, phase I, phase II and enzymes
involving in drug biotransformation, oxygen and transformation of drugs and
substances, extrahepatic biotransformation of drugs, biotransformation pathways
and mechanisms of drug in various dosage forms.
550 206 Drug Biotransformation II 3(3-0-6)
Pre-requisite : 550 205 Drug Biotransformation I
Physiological and pathological factors affecting drug biotransformation,
induction and inhibition, drug biotransformation resulting in drug-drug interaction,
drug-substance or drug-food interaction, application of drug biotransformation in
drug formulation, pharmacokinetics, and evaluation of drug therapy.
550 207 Nutrition and Drug Interactions 2(2-0-4)
Pre-requisite : 562 321 Biopharmaceutics and Pharmacokinetics
Study of food-drug interaction effects including effects of drug on food
metabolism and requirement in patient, and effects of patient nutrition on drug
metabolism.
25
550 208 Nutritional Assessment 2(1-3-2)
Pre-requisite : 561 202 Biopharmacy IV
Evaluation of nutrition status in individuals; view on food intakes,
biochemical and clinical measurements, and body size index, including disease
and malnutrition prevention.
550 209 Minerals and Vitamins in Nutrition 2(1-3-2)
Pre-requisite : 561 102 Biopharmacy II
Minerals and vitamins; novel data of usable food sources, nutritional value
and requirements, effects of malnutrition and overuptake, including content
analysis in food.
550 210 Immunopathology 3(3-0-6)
Pre-requisite : 561 203 Biopharmacy V
Immunological pathology involve in systemic functions and autoimmune
disease.
550 211 Medical Equipment and Accessories 2(1-3-2)
Medical equipment and accessories, with emphasis on their usage,
handling, and storage.
550 212 Intravenous Admixture 2(1-3-2)
Pre-requisite : 567 224 Pharmaceutical Technology IV
Preparation of intravenous admixture, focusing on preparation process,
incompatability, stability, and concepts in establishing the services for
intravenous admixture and parenteral nutrition in the hospital.
550 213 Radiopharmaceuticals 2(2-0-4)
Radioactive agents, safety and toxicity, preparations and use of
radiopharmaceutical products diagnosis for treatment in pateints.
26
550 214 Hospital Pharmacy 4(3-3-6)
Administrative systems and organizations of pharmaceutical services in
various accredited institutes of health services including hospitals, health service
centres and others, emphasizing on professional practice and duties of
personnels engaging in pharmaceutical services of different administrative levels
and size of hospitals.
550 215 Pharmacoepidemiology 3(2-3-4)
Pre-requisite : 080 144 Principles of Research
563 251 Basic Public Health
Study of drug consumers' behavior by using concepts of epidemiology ;
including evaluation of effectiveness based on socioeconomic status and culture
; rational use of drugs, individual and social impact, as well as preventive
measures and problem solving.
550 216 Pharmacoeconomics 2(2-0-4)
Pre-requisite : 563 255 Basic Pharmacy Administrations II
Application of economic concepts in health services, pharmaceutical
activities, drug system and pharmaceutical products; emphasizing on human
resource management policy, pharmaceutical industry, marketing, and price
regulation ; economic evaluation methods of health care and services.
550 217 Environmental Clinical Toxicology 3(1-6-2)
Pre-requisite : 565 243 Toxicology
Environmental pollution with emphasis on etiology, pathophysiology,
impact on human and animal health, and ecological system ; threshold limits,
prevention, and management of toxicant exposure also addressed.
550 218 Veterinary Pharmaceutical Products 3(2-3-4)
Pre-requisite : 565 243 Toxicology
Veterinary pharmaceutical products including commercially available
medications, indications, uses, dosage calculation, precaution and
27
contraindication, drug interaction, storage, as well as residual test ; law and
legislation related to veterinary medicines.
550 219 Environmental Toxicology 4(3-3-6)
Pre-requisite : 565 243 Toxicology
Effects of environmental chemical contaminants on living beings,
emphasizing potential causes and incidences, phenomena, safety limits and
ecological environments.
550 220 New Drugs and Current Drugs 2(2-0-4)
Pre-requisite : 565 242 Pharmacology II
New drug development and comparative evaluation with currently
available products on pharmacokinetics, pharmacodynamics, therapeutic
indication, dosage form and administration, adverse reaction and drug
interaction.
550 221 Applied Pharmacognosy 2(2-0-4)
Pre-requisite : 565 242 Pharmacology II
566 211 Pharmacognosy II
Application of pharmacognostic knowledge for current use of medicinal
plants in Thailand emphasizing on products frequently used in the country:
integration of both modern medical knowledge and indigeneous knowledge ;
selection of appropiate information and rational counselling based on scientific
evidences.
550 222 Molecular Biotechnology for Pharmacists 3(3-0-6)
Pre-requisite : 561 211 Biological Products
Principles of molecular biotechnology, recombinant DNA technology,
molecular biology researches, regulation of gene expression, synthesis of
various proteins, protein engineering, product engineering for use in therapy,
prevention and diagnosis in primitive and higher cells; including biotechnology
application in therapy.
28
550 223 Pharmaceutical Quality Control III 4(2-6-4)
Pre-requisite : 564 231 Pharmaceutical Quality Control II
Principles and advanced techniques in pharmaceutical analysis focusing
on the application of sophisticated instruments.
550 224 Pharmaceutical Quality Control of Food and Cosmetics 4(3-3-6)
Pre-requisite : 564 231 Pharmaceutical Quality Control II
Quality control of food and cosmetics by identification and quantitative
analysis of active ingredients and impurities.
550 225 Biomedical Analysis 4(3-3-6)
Pre-requisite : 564 231 Pharmaceutical Quality Control II
Principles, techniques and methods of the quantitative analysis of drugs
and/or their metabolites in biological fluids, focusing on inquisition, data
evaluation, planning and developing of analytical process.
550 226 Pharmaceutical Chemistry Analysis of Dietotherapeutics 3(2-3-4)
Pre-requisite : 564 231 Pharmaceutical Quality Control II
Compositions of the substances used in dietotherapeutics in the aspects
of sources, storage, quality control and analysis and uses of special techniques
in determination of stability index as well as identification and determination of
other ingredients
550 227 Mutation Evaluation of Drugs and Envirommental Toxic
Substances 3(1-6-2)
Pre-requisite : 565 243 Toxicology
Mutagenicity test and evaluation of drugs and environmental toxicants
employing both current and new protocols and techniques; rationale and
necessity of the investigation are discussed as well.
550 228 Basic Cellular and Molecular Pharmacology 3(3-0-6)
Pre-requisite : 565 242 Pharmacology II
Basic topics in cellular and molecular mechanism of drug actions covering
receptor structure and function, intracellular communication and signal
29
transduction pathways, functional characterization of signaling molecules and
target cell response and effector mechanisms.
550 229 Experimental Pharmacology 2(0-6-0)
Pre – requisite : 565 261 Pharmacology Laboratory I
Basic principles of experimentation in pharmacology covering basic
techniques and protocols for studying in cellular and molecular levels, animal
models for studying drug actions in particular diseases and clinical trials.
550 230 Separation Technique in Pharmaceutical Sciences 3(2-3-4)
Pre-requisite : 564 231 Pharmaceutical Quality Control II
566 211 Pharmacognosy II
Separation of bioactive and valuable compounds from medicinal plants for
analyze, identification, structure elucidation and production process
development.
550 231 Indigenous Medicines 4(3-3-6)
Pre-requisite : 565 242 Pharmacology II
566 211 Pharmacognosy II
Uses of finish-produced indigenous medicines in rural areas, conceptual
thinkings and trends of people in general on indigenous medicines, local and
modernized pharmaceutical galenical formulations, preparations and evaluations
of indigenous medicines ; applications of phytochemical techniques in analyses.
550 232 Agropharmaceutical Sciences 4(3-3-6)
Pre-requisite : 566 211 Pharmacognosy II
Chemical and pharmaceutical agents used in agriculture and
agroindustries, including insecticides, rodenticides, pesticides, auxins and others
of agroindustrial interests, pharmaceutical therapeutics in veterinary sciences,
animal foodstuffs, fertilizers, fungicides, herbicides; roles and interrelationship of
people in agriculture and agro-industries with pharmacists working in rural
areas.
30
550 233 Biotechnology of Medicinal Plants 3(2-3-4)
Application of biotechnology for production of medicine/ bioactive
compounds, setting up operation and culturing room, preparation of culturing
medium, sterile materials and containers ; techniques and factors affecting the
production including application of genetic engineering techniques ;
development and storage of cell lines.
550 234 Novel Drug Delivery System 2(2-0-4)
Pre-requisite : Senior standing
Novel drug delivery system, focusing on techniques and preparation of
stable products with high productivity.
550 235 Cosmeticology 4(2-6-4)
Pre-requisite : 567 223 Pharmaceutical Technology III
Principle and techniques of cosmeticology including flavor, color and
stability of all cosmetic products; preparation techniques, safety evaluation,
selection and quality control of cosmetic products.
550 236 Manufacturing Management 4(3-3-6)
Organizational management in pharmaceutical industrial firms, production
planning and controling, personnel administration; including purchasing,
distributing and storing system, as well as mechanical system.
550 237 Quality Control and Quality Assurance Systems 4(3-3-6)
Planning of operation in quality control and assurance system in
pharmaceutical industrial firms covering raw materails unto finished
pharmaceutical products; planning of management by using various appropriate
models; principles and conceptual aspects of good professional manufacturing
practice.
31
550 238 Tablet Coating 3(2-3-4)
Pre-requisite : 567 221 Pharmaceutical Technology II
Advanced technology and arts of tablet coating especially sugar coating
and film coating, including principles and techniques of preparation, evaluation
and standardization of dosage forms, process development and problem
solving.
550 239 Introductory Polymer Sciences in Pharmacy 2(2-0-4)
Pre-requisite : 567 225 Pharmaceutical Technology V
Basic knowledge and physico-chemical properties of medical polymer
both in the solution and solid state covering technology of polymer modification
and the application of novel polymer for medical usage.
550 240 Industrial Hygiene 4(3-3-6)
Industrial hygiene of employers and employees in pharmaceutical
industry, preventive measures and precautions of dangers and hazards from
accidents, physico-chemical factors and neuropsychological factors on bodily
and mental healths of employees; hygiene and industrial health services, laws
and regulation, recreations and social welfares.
550 241 Community Pharmacy 3(2-3-4)
Pre-requisite : 563 251 Basic Public Health
Concepts and trends of community pharmacy management in the world
; application of management process in constructing and operating drugstores.
550 242 Public Health Pharmacy 3(2-3-4)
Pre-requisite : 563 251 Basic Public Health
Concepts of administration and innovations of health system ;
development and trends of public health in the world, including practicing skill
for problems solving.
32
550 243 Pharmacists and Rural Health Care 4(2-6-4)
Pre-requisite : 563 251 Basic Public Health
Roles of pharmacists in health problem solving in rural areas ; correlation
of health problems and other rural problems, emphasizing on rural areas in
western region of Thailand.
550 244 Drug Marketing and Detailing 3(2-3-4)
Pre-requisite : 550 366 Pharmacotherapeutics II
563 255 Basic Pharmacy Administrations II
Concepts, principles, theories, procedures and other relevant dynamic
factors concerning management of pharmaceutical marketing; socio- economics
implications of marketing and detailing activities, business administration and
higher detailing techniques including policy planning, operating plans and
various aspects of development and control of medical representations.
550 251 Professional Practice I 1(0-3-0)
Course Evaluation : S/U
Pre-requisite : 3rd year students
Undergraduate practice to experience professional roles in various areas
of pharmacy.
550 301 Special Problems in Pharmaceutical Sciences 3(2-3-4)
Pre-requisite : Senior standing
Theoretical and laboratory studies of problems in biopharmacy,
pharmacology and toxicology, pharmaceutical chemistry, pharmacognosy and
pharmaceutical technology.
550 306 Current Topics in Pharmaceutical Sciences 2(2-0-4)
Pre-requisite : Senior standing
Academic advancements of interests in pharmaceutical sciences.
550 307 Advanced Biopharmacy 3(3-0-6)
Pre-requisite : 565 242 Pharmacology II
33
Biopharmaceutical aspects in normal and pathological states, emphasizing
on chemotherapy, metabolism, mechanism of biological changes; principle of
evaluation, including practical guidelines and factors affecting chemotherapy.
550 311 Drug Information in Pharmaceutical Care 3(2-3-4)
Pre-requisite : 565 352 Pharmacotherapeutics I
Drug information sources in pharmaceutical care and drug information
services for pharmacists healthcare professionals, patients, and public;
management of drug information in pharmaceutical care.
550 312 Current Topics in Pharmacy Practice 4(3-3-6)
Pre-requisite : 562 361 Pharmacy Practice
Keeping up-to-date with recent knowledge in pharmacy practice
concerning disease management, pharmaceutical care, recent research;
discussion of new concepts based on research evidence in pharmacy practice.
550 315 Advanced Biopharmaceutics 3(2-3-4)
Pre-requisite : 562 321 Biopharmaceutics and Pharmacokinetics
Factors affecting the rate and amount of drug entering the body from
various pharmaceutical products, consequences of drug administration via
different routes; influences of dosage and dosing interval on the rate and
amount of drug entering the body; study focusing on the recent development in
this field.
550 316 Clinical Pharmacokinetics 2(1-3-2)
Pre-requisite : 562 321 Biopharmaceutics and Pharmacokinetics
Application of pharmacokinetics in adjusting dosage regimen;
therapeutic drug monitoring in individual patients, measuring and interpreting
drug concentration in blood and biological fluids, assessing risk of toxicity of
drug dosage.
34
550 317 Evidence Base in Pharmaceutical Care 3(2-3-4)
Pre-requisite : 562 361 Pharmacy Practice
Basic concepts and principles of drug therapy based on research
evidence ; research methodology and statistics in clinical research ; retrieval
and critical appraisal of research evidence.
550 318 Outcomes Drug Assessment 3(2-3-4)
Pre-requisite : 562 361 Pharmacy Practice
Assessment of treatment outcomes in terms of quality of life and
economic aspects; application in evaluating healthcare services and
pharmaceutical products.
550 319 Drug Assessment 2(1-3-2)
Pre-requisite : 562 321 Biopharmaceutics and Pharmacokinetics
Drug development process and clinical trials with the emphasis on data
management and evaluation.
550 320 Drug use Evaluation I 3(2-3-4)
Pre-requisite : 565 352 Pharmacotherapeutics I
Evaluation of drug use with respect to therapeutic values, indication,
dosage regimen; assessing drug utilization in terms of amount and cost;
measuring and evaluating efficacy and safety of drug treatment, focusing on
basic drug groups with high impacts on health and public health system.
550 321 Drug use Evaluation II 3(2-3-4)
Pre-requisite : 565 352 Pharmacotherapeutics I
Extended study of drug use evaluation emphasizing on the use of drugs
with serious adverse effects.
550 322 Pharmaceutical Synthesis 3(2-3-4)
Pre-requisite : 564 212 Pharmaceutical Chemistry III
Techniques used in drugs synthesis, reaction control, quantitative analysis
and identification of synthesized products
35
550 324 Evaluation of Drug Action 2(2-0-4)
Pre-requisite : 565 242 Pharmacology II
Study of new drugs emphasizing on drug action, drug efficacy and
adverse reactions by comparing with currently available drugs with similar
mechanism of actions and therapeutic indication; clinical trials and
postmarketing evaluation are also discussed.
550 325 Pharmacology of Neuropsychoactive Drugs 4(3-3-6)
Pre-requisite : 565 242 Pharmacology II
Therapeutic and other pharmacological agents with specific actions or
side-effect actions as neuropsychological agents, narcotic and social addictives,
and hallucinogenics, their toxic and hazardous effects, appropriate and specific
treatments; public health problems relating to such agents, health education and
preventive measures.
550 326 Pharmacology of Cardiovascular Drugs 3(2-3-4)
Pre-requisite : 565 242 Pharmacology II
Academic advancement in cardiovascular drugs including cellular and
molecular pharmacology and natural product development for cardiovascular
diseases; evaluation of current uses and problems related to cardiovascular
drugs.
550 327 Pharmacology of Gastrointestinal Drugs 3(2-3-4)
Pre-requisite : 565 242 Pharmacology II
Academic advancement in gastrointestinal drugs including cellular and
molecular pharmacology and natural product development for gastrointestinal
diseases; evaluation of current uses and problems related to gastrointestinal
drugs.
550 330 Clinical Pharmacology 3(2-3-4)
Pre-requisite : 565 352 Pharmacotherapeutics I
Basic clinical pharmacology, rational use and selection of drugs for
therapeutic indication with relevance to pharmacokinetics/ pharmacodynamics
consideration, adverse drug reactions and interactions.
36
550 331 Pharmaceutical Packagings 2(2-0-4)
Properties, advantages and disadvantages of materials used for
pharmaceutical packagings, including evaluation and storage.
550 332 Pharmacy Law 1(1-0-2)
Drug law and regulations related to pharmaceutical practices ;
responsibility of pharmacists to consumers and society; application of law
concepts to solve the problems in case studies.
550 333 Evidence Base Phytotherapy 2(2-0-4)
Pre-requisite : 565 242 Pharmacology II
566 211 Pharmacognosy II
Evaluation and analysis of efficiency and efficacy of medicinal plants and
products derived from medicinal plants for therapeutic and health promotion
purposes based on scientific knowledge including complementary medical
concepts emphasizing on medicinal plants and pharmaceutical products of
medicinal plants available in Thailand.
550 334 Current Therapy in Pharmaceutical Care 4(3-3-6)
Pre-requisite : 562 361 Pharmacy Practice
Keeping up-to-date with the recent knowledge in pharmaceutical care,
presentation and discussion of present concepts concerning the advancement in
pharmacotherapy.
550 338 Principle of Medicinal Chemistry 3(3-0-6)
Pre-requisite : 564 212 Pharmaceutical Chemistry III
565 242 Pharmacology II
Process and the method of structure elucidation of compounds used as
drugs by the application of organic chemistry, biochemistry and pharmacology,
including metabolism, process and chemical mechanism involving the structure
change.
37
550 340 Drug Designs 4(3-3-6)
Pre-requisite : 564 212 Pharmaceutical Chemistry III
565 242 Pharmacology II
Integrated knowledges of structure and activity relationships in designing
new drugs with desired physical, biological and pharmacokinetic/dynamic
properties, using computer application.
550 343 Advanced Pharmacology and Toxicology 3(3-0-6)
Pre-requisite : 565 242 Pharmacology II
565 243 Toxicology
Integrated concepts, research, and experimental approaches in
investigative pharmacology as well as biochemical toxicology of drugs/
compounds affecting functions of endocrine system, cardiovascular and renal
system, autonomic and central nervous systems, emphasizing on the levels of
drug/compound-receptor interaction and intracellular signal transduction
pathways.
550 347 Research and Development in Medicinal Plants 3(2-3-4)
Pre-requisite : 080 144 Principles of Research
565 242 Pharmacology II
566 211 Pharmacognosy II
Systematic study and research, compilation and development of data of
medicinal plants used in Thai remedies.
550 349 Pharmaceutical Formulation and Development 4(2-6-4)
Pre-requisite : Senior standing
Principle and technique for improvement of the physical properties and
biological action of dosage forms, as well as preparation techniques.
550 351 Professional Practice II 3(0-9-0)
Course Evaluation : S/U
Pre-requisite : with the consent of the faculty
38
A continuity of professional practice emphasizing major areas of hospital
pharmacy, industries, public health institutes, community services, including
other accredited institutes affiliated with pharmaceutical sciences.
550 352 Professional Practice III 5(0-15-0)
Course Evaluation : S/U
Pre-requisite : Senior standing and with consent of the faculty
A continuity of professional practice emphasizing on pharmaceutical care
or pharmaceutical sciences or pharmaceutical informatics.
550 355 Pharmaceutical Biotechnology 3(2-3-4)
Pre-requisite : 561 203 Biopharmacy V
Integrated study and application of gene, protein, genetic engineering,
biotechnology, nanotechnology and drug delivery systems in the production of
pharmaceuticals and cosmetics.
550 356 Pharmacogenomics 2(2-0-4)
Pre-requisite : 561 203 Biopharmacy V
Integrated study of genetic differences in individuals on the susceptibility
of diseases, drug responses, drug adverse effect and toxicity, emphasizing on
the research and development of drugs for efficient therapy of individuals.
550 359 Computer in Pharmacy 3(2-3-4)
Principles of major components of computer system, hardware and
softwares co-functions; concepts of data evaluation, programming and inventory
controls; application of computer in pharmacy with an emphasis on industrial
pharmacy, hospital pharmacy and community pharmacy.
550 360 Computerized Applications in Pharmaceutical Sciences 3(1-6-2)
Data-integrated programs in pharmaceutical applications; emphasis on
drug store and database administration, librarian printed documents in health
sciences and related fields, electronic communication, drug information systems,
sources of pharmaceutical information and problem solving on computerized
39
and database basis; including database development in pharmaceutical
sciences.
550 361 Seminar in Pharmaceutical Sciences 1(0-3-0)
Pre-requisite : Senior standing
Searching and compiling data in pharmaceutical sciences, analysis of
information collected for presentation and discussion.
550 362 Drug Information Services 3(2-3-4)
Pre-requisite : Senior standing
Study and practice of drug information service covering searching and
evaluating drug information sources, critically appraising the literature; data
management system; communication skills.
550 363 Consumer Protection in Foods and Drugs 3(2-3-4)
Pre-requisite : 550 332 Pharmacy Law
563 251 Basic Public Health
Concepts, policy, plans and regulation in consumer protection;
consumers' right, implementation in public and private sectors, pharmacists' role
in consumer protection; strategic plans with an emphasis on foods, drugs and
health products.
550 364 Special Problems in Community Pharmacy 3(2-3-4)
Pre-requisite : 563 251 Basic Public Health
563 255 Basic Pharmacy Administrations II
Problem solving in pharmaceutical practice emphasizing retail pharmacy,
marketing, display advertising, and interrelationship between pharmacists and
community.
550 365 Advanced Clinical Pharmacy 4(3-3-6)
Pre-requisite : 550 366 Pharmacotherapeutics II
In depth and integrated study and practice of clinical pharmacy
concerning drug information service, pharmacy counselling, therapeutic drug
40
monitoring, dietotherapy, practice in patient wards, interpretation of laboratory
results, drug therapy monitoring, preparation of intravenous admixture and toxic
drugs.
550 366 Pharmacotherapeutics II 4(3-3-6)
Pre-requisite : 565 241 Pharmacology I
565 242 Pharmacology II
Basics of pathophysiology, etiology, and drug therapy in the diseases
and disorders of genitourinary system, respiratory system, endocrine system,
cardiovascular system, gastroenterology system, electrolyte balance, and
infectious diseases, with the emphasis on integrated study and practice in drug
therapy monitoring employing case studies and visit to practice sites.
550 367 Pharmacotherapeutics III 4(3-3-6)
Pre-requisite : 565 241 Pharmacology I
565 242 Pharmacology II
Pathophysiology and pharmacotherapy of musculoskeletal disorders,
hematological, immunological, neurological, psychological, dermatological, eye-
ear-nose-throat, obstetric-gynecological, cancer diseases ; rational uses of
drugs in pediatrics, pregnancy and geriatrics, integrated problem solving and
plan for rational drug use and monitoring, including problem-solving skills in
clinical settings.
550 368 Public Health Administration 3(2-3-4)
Pre-requisite : 563 255 Basic Pharmacy Administrations II
Approaches in public health administration, structure, policy and
strategy of health system development; obstructions in implementation and
administration process; development in public health pharmacy especially in
hospital and health centers.
550 369 Special Problems in Pharmaceutical Care 2(1-3-2)
Pre-requisite : 562 361 Pharmacy Practice
Problems concerning pharmaceutical care focusing on pharmacotherapy.
41
550 370 Research and Development of Pharmaceutical Products 2(2-0-4)
Pre-requisite : Senior standing
Research and development processes of pharmaceuticals, cosmetics,
biological products and herbal medicine, including pharmacology and toxicology
of drugs, structural and dosage form designs, as well as clinical assessment.
550 371 Management in Pharmaceutical Sciences 2(2-0-4)
Pre-requisite : 563 255 Basic Pharmacy Administrations II
Planning, personnel management, purchasing and storing system, as well
as clinical assessment for research and development of pharmaceutical
products.
550 372 Quality Assurance in Pharmaceutical Sciences 3(3-0-6)
Concepts of quality assurance in pharmacy focusing on national and
international standards, conceptional agreements and regulations.
550 373 Communication and Health 3(1-6-2)
Pre-requisite : 550 366 Pharmacotherapeutics II
565 242 Pharmacology II
Communication skills with patients and health care professionals in
pharmacy practices.
550 374 Strategy in Pharmacy Administration 3(2-3-4)
Pre-requisite : 563 255 Basic Pharmacy Administrations II
Strategy in pharmacy management emphasize on organization and
personnel management, small and medium enterprises, inventory control,
financial and cost accounting; including managerial costing for evaluation and
decision making.
550 375 Pharmaceutical Information Management 3(2-3-4)
Pharmaceutical specialties available in drug information, searching
from primary, secondary and tertiary sources, categorization, evaluation, data
management, and provision ; analysis of drug information from leaflets and
42
other sources; presentation techniques, as well as law and ethics in
management of pharmaceutical information.
550 399 Senior Project 1(0-3-0)
Pre-requisite : Senior standing and 080 144 Principles of Research
Preparatory programme for Pharmacy students to achieve higher
standard of scholastic pharmacists to serve in various organizations and
regions, emphasizing on team working for problem solving, administration of
information system, pharmaceutical and medical inventory administration,
production and quality control, and academic services to community.
561 101 Biopharmacy I 2(2-0-4)
Pre-requisite : 512 102 General Biology II
Integrated study of cell structures, properties and functions of cell
organelles, methods in biochemistry, structures and functions of biomolecules in
normal and pathological states.
561 102 Biopharmacy II 2(2-0-4)
Pre-requisite : 561 101 Biopharmacy I
Metabolism of biomolecules, principle of nutrition, integrated study of
cell biology with special emphasis on cell function and molecular signelling.
561 103 Basic Molecular Biology for Pharmacists 1(1-0-2)
Pre-requisite : 561 102 Biopharmacy II
Basic principles in molecular biology and genetics; structure and function
of genes and chromosomes, molecular controlling, principle aspects of genetic
engineering in pharmaceutical applications.
561 131 Biopharmacy Laboratory I 1(0-3-0)
Pre-requisite : 550 102 Basic Pharmaceutical Laboratory
561 101 Biopharmacy I *
* can be co-requisite
Laboratory practice to understand basic techniques and contents related
to 561 101 Biopharmacy I.
43
561 201 Biopharmacy III 3(3-0-6)
Pre-requisite : 561 101 Biopharmacy I
Integrated anatomical, biochemical and physiological study of structures,
functions and interaction of human cells, tissues and organ system in normal
state ; emphasizing on nervous system, musculoskeletal system, endocrines,
and reproductive system.
561 202 Biopharmacy IV 2(2-0-4)
Pre-requisite : 561 201 Biopharmacy III
Integrated study of anatomical, biochemical and physiological controls of
structures, functions and interaction of human cells, tissues and organ system in
normal state ; emphasizing on hematology, cardiovascular, urinary, respiratory
and gastrointestinal systems, including homeostasis.
561 203 Biopharmacy V 4(4-0-8)
Pre-requisite : 561 102 Biopharmacy II
Biochemical and physiological aspects of pathogenic microorganisms,
preventives, principles and techniques of asepsis, immunity, parasitic
infestations in man and animals, animal-born diseases, identification of
microorganisms and tests of susceptibility towards medicines, application of
microorganisms in pharmaceutical interests, also covering other principle
aspects and techniques in pharmaceutical microbiology, parasitology and
immunology.
561 211 Biological Products 2(2-0-4)
Pre-requisite : 561 203 Biopharmacy V
Origins, preparations and standardization, utilization and precautions of
biological products including vaccines, sera, toxoids, allergenics, anti-venoms,
anti-rabies and others; related biotechnological methods, laws and regulations
concerning utilization and controls of such products.
561 231 Biopharmacy Laboratory III 1(0-3-0)
Pre-requisite : 561 201 Biopharmacy III *
44
* can be co-requisite
Laboratory practice to understand basic techniques in physiology and
contents related to 561 201 Biopharmacy III.
561 232 Biopharmacy Laboratory IV 1(0-3-0)
Pre-requisite : 561 202 Biopharmacy IV *
* can be co-requisite
Laboratory practice in biochemical and physiological regulatory systems of
cells, tissues and organs; with contents related to 561 202 Biopharmacy IV.
561 233 Biopharmacy Laboratory V 1(0-3-0)
Pre-requisite : 561 203 Biopharmacy V *
* can be co-requisite
Laboratory practice in biochemical and physiological aspects of
pathogenic microorganisms, preventives, principles and techniques of asepsis,
immunity, parasitic infestations in man and animals, identification of
microorganisms and tests of susceptibility towards medicines, application of
microorganisms in pharmaceutical interests, also covering other principle
aspects and techniques with contents related to 561 203 Biopharmacy V.
562 321 Biopharmaceutics and Pharmacokinetics 3(3-0-6)
Pre-requisite : 565 242 Pharmacology II *
* can be co-requisite
Effects of physical and chemical properties of drug, biological and other
factors on dynamics and kinetics of drug absorption, distribution, metabolism,
and excretion; bioavailability; mathematical models; the application of
pharmacokinetic principles in assessing pharmaceutical products regarding
pharmacological and pharmacotherapeutic aspects.
562 361 Pharmacy Practice 4(3-3-6)
Pre-requisite : 562 321 Biopharmaceutics and Pharmacokinetics
Basic concepts and principles in clinical pharmacy covering documentary
system and essential parameters in pharmaceutical care, with the emphasis on
identifying, correcting, and preventing drug-related problems.
45
563 254 Basic Pharmacy Administrations I 2(2-0-4)
Fundamental principles of management in public and private sectors,
types of business, risk management and insurances ; basic principle of
economics and its application in pharmacy administration.
563 255 Basic Pharmacy Administrations II 2(1-3-2)
Pre-requisite : 563 254 Basic Pharmacy Administrations I
Application of managerial accounting , cost and strategy in administration
of pharmacy services.
564 111 Pharmaceutical Chemistry I 1(1-0-2)
Pre-requisite : 513 102 General Chemistry II
Sources, pharmaceutical preparations, identification, purification and purity
rubrics, limit test, therapeutic uses, precaution and storage of inorganic
pharmaceutical compounds.
564 121 Pharmaceutical Chemistry Laboratory I 1(0-3-0)
Pre-requisite : 564 111 Pharmaceutical Chemistry I *
* can be co-requisite
Laboratory in pharmaceutical preparation, identification, purification,
therapeutic uses, precaution and storage of inorganic and organic
pharmaceutical compounds.
564 131 Pharmaceutical Quality Control I 3(3-0-6)
Pre-requisite : 513 102 General Chemistry II
Fundamental and integrated knowledges of physical control of raw
materials and pharmaceuticals, including principles and qualitative analytical
techniques involving various physical analytical methods, emphasizing analysis
and interpretation in pharmacy.
564 132 Pharmaceutical Quality Control Laboratory I 2(0-6-0)
Pre-requisite : 550 102 Basic Pharmaceutical Laboratory
564 131 Pharmaceutical Quality Control I*
* can be co-requisite
46
Quality control laboratory of raw materials and pharmaceuticals according
to pharmacopoeias by various analytical methods which conform to the contents
in 564 131 Pharmaceutical Quality Control, emphasizing analysis and
interpretation in pharmacy.
564 211 Pharmaceutical Chemistry II 3(3-0-6)
Pre-requisite : 513 250 Organic Chemistry
Organic pharmaceutical and medicinal compounds from synthesis,
pharmaceutical therapeutics, structure-activity relationships of pharmaceuticals,
stability, purity, identification, principles and techniques of pharmaceutical
syntheses covering those compounds employing in neuromuscular,
cardiovascular and nephrotic system.
564 212 Pharmaceutical Chemistry III 4(4-0-8)
Pre-requisite : 564 211 Pharmaceutical Chemistry II
Pharmaceutical chemistry of synthetic compounds employing as
antibiotics, hormones, anti-inflammatory drugs, antineoplastics and other
categories.
564 231 Pharmaceutical Quality Control II 3(3-0-6)
Pre-requisite : 564 131 Pharmaceutical Quality Control I
Pharmaceutical quality control focusing on principles and application of
advanced instrumental analysis in pharmaceutical quality control including
structure elucidation, separation techniques, data analysis and other special
techniques.
564 233 Pharmaceutical Quality Control Laboratory II 1(0-3-0)
Pre-requisite : 564 231 Pharmaceutical Quality Control II *
* can be co-requisite
Laboratory of pharmaceutical quality control emphasizing on practical
approaches of advanced instrumental analysis in pharmaceutical quality control
including structure elucidation, separation techniques, data analysis and other
special techniques.
47
565 241 Pharmacology I 3(3-0-6)
Pre-requisite : 561 202 Biopharmacy IV *
* can be co-requisite
Pharmacological principles and concepts of drugs as therapeutic
agents, indications and contra-indications, side-effects and precautions, adverse
drug reactions, dosage and ulilization, and mechanisms of actions at molecular,
cellular and organ levels in terms of pharmacodynamics, covering therapeutic
agents acting on autonomic and central nervous systems.
565 242 Pharmacology II 4(4-0-8)
Pre-requisite : 561 202 Biopharmacy IV *
* can be co-requisite
Pharmacology of therapeutic agents acting on cardiovascular and renal
systems, gastrointestinal system, respiratory system and those as antibiotics,
antineoplastics, hormones and immunological products.
565 243 Toxicology 2(2-0-4)
Toxicology of therapeutic agents, cosmetics, food additives, hazardous
toxicants, household chemicals, agents used in agriculture, pollutants and
narcotics, covering principles and aspects of mechanisms of actions, antidotal
therapy and treatments, safety measures, methods in qualitative and
quantitative analyses including forensic confirmation analysis.
565 261 Pharmacology Laboratory I 1(0-3-0)
Pre-requisite : 565 241 Pharmacology I *
* can be co-requisite
Laboratory course on therapeutic uses of drugs, precaution and adverse
drug reaction, indications and contraindication, pharmacokinetics
/pharmacodynamics of drugs for autonomic and central nervous system.
565 263 Toxicology Laboratory 1(0-3-0)
Pre-requisite : 565 243 Toxicology *
* can be co-requisite
48
Laboratory course on toxic actions of drugs, cosmetics, food additive,
household products, agricultural products as well as drug of abuse; emphasizing
on toxic symptoms and management; primary analyses as well as forensic
confirmation test of toxicants.
565 352 Pharmacotherapeutics I 3(3-0-6)
Pre-requisite : 565 241 Pharmacology I
565 242 Pharmacology II
Rational use and selection of drugs in various pathological disorders,
including vitamins and food supplement; pharmacogenetic basis of drug
responses; drug use in medical emergency.
566 111 Pharmacognosy I 3(3-0-6)
Pre-requisite : 566 101 Pharmaceutical Botany
Phytochemical study of medicinal plants, including biosynthesis,
decomposition, natural sources, classification of natural compounds from plants,
animals and minerals as well as application in medical and pharmaceutical
purposes.
566 121 Pharmacognosy Laboratory I 1(0-3-0)
Pre-requsite : 566 111 Pharmacognosy I *
* can be co-requisite
Extraction of natural products, screening, analyse, and identification
emphasizing on medicinal plants.
566 211 Pharmacognosy II 2(2-0-4)
Pre-requisite : 566 111 Pharmacognosy I
Extended study of natural products, emphasizing on identification,
standardization, preparation and formulation of natural medicine, plant tissue
culture, and evaluation for medicinal purposes.
566 221 Pharmacognosy Laboratory II 1(0-3-0)
Pre-requisite : 566 111 Pharmacognosy II *
* can be co-requisite
49
Quality control, setting up standardization, identification and preparation
of crude drugs and herbal products, plant tissue culture, and herbal drug
evaluation emphasizing on phytochemistry and pharmacology.
567 221 Pharmaceutical Technology I 2(2-0-4)
Pre-requisite : 550 156 Introduction to Pharmaceutical Dosage
Forms and Technology
Drug dosage forms, introductory Good Manufacturing Practice, physical
properties of materials, including technique of solubilization and solution
properties ; preparation, storage, and stability of solution dosage forms also
discussed.
567 222 Pharmaceutical Technology II 3(3-0-6)
Pre-requisite : 550 156 Introduction to Pharmaceutical Dosage
Forms and Technology
Pharmaceutical powder technology such as size and size distribution,
measurement of particle size, flowability and other properties related to the
preparation of solid dosage forms especially tablets, capsules and coated-
tablets.
567 223 Pharmaceutical Technology III 3(3-0-6)
Pre-requisite : 550 156 Introduction to Pharmaceutical Dosage
Forms and Technology
Basic concepts, preparation techniques, physical properties, formulation
development, and stability of heterogeneous solid, liquid and semisolid dosage
forms.
567 224 Pharmaceutical Technology IV 2(2-0-4)
Pre-requisite : 567 221 Pharmaceutical Technology I
Technology and arts of manufacturing of sterile solid, semi-solid and
solution dosage forms, focusing on injectable dosage forms, eye preparations,
and parenteral dosage forms ; quality control of dosages, Good Manufacturing
Practices, storage, and packaging also concerned.
50
567 225 Pharmaceutical Technology V 2(2-0-4)
Pre-requisite : 550 156 Introduction to Pharmaceutical Dosage
Forms and Technology
Comprehensive study of knowledge and technology for development of
novel dosage forms, aerosols, radiopharmaceuticals, packaging selection and
the application of statistics for products evaluation also included.
567 261 Pharmaceutical Technology Laboratory I 1(0-3-0)
Pre-requisite : 567 221 Pharmaceutical Technology I *
* can be co-requisite
Practicing of technology and arts for development of solution dosage
forms, their quality controls according to pharmacopoeia, packaging selection
and process validation.
567 262 Pharmaceutical Technology Laboratory II 1(0-3-0)
Pre-requisite : 567 222 Pharmaceutical Technology II *
* can be co-requisite
Practicing of technology and arts for development of solid dosage forms
especially tablets and capsules, their quality controls according to
pharmacopoeia, packaging selection and process validation.
567 263 Pharmaceutical Technology Laboratory III 1(0-3-0)
Pre-requisite : 567 223 Pharmaceutical Technology III *
* can be co-requisite
Practicing skill in development of heterogeneous solid, liquid and semi-
solid dosage forms, techniques of preparation and stabilization of dosage forms,
their quality controls according to pharmacopoeia, packaging selection and
process validation.
567 264 Pharmaceutical Technology Laboratory IV 1(0-3-0)
Pre-requisite : 567 224 Pharmaceutical Technology IV *
* can be co-requisite
51
Practicing of technology and arts for development of sterile dosage forms,
including large and small volume parenteral dosage forms ; their quality controls
according to pharmacopoeia, packaging selection and process validation.
18. Quality Assurance
The program will be subjected to standard quality assurance procedure set by the
Ministry of Education.
52
Name Qualification Research
Experience
Work load
For this program
(hours/week)
1. Assoc.Prof. Dr. Sindchai
Keokitichai
B.S.(Pharm) Mahidol (1972)
M.Phil. University of London (1978)
Ph.D. University of London, UK. )1980(
Appendices 1.07
2. Prof.Dr.Vira Kasantikul M.D.Chulalongkorn (1972)
Residency Anatomic Pathology : Vanderbilt
University. (1978)
Fellowship Neuropathology : University of
California at Los Angeles, USA. (1982)
Appendices 0.80
3. Ms.Chantana
Wessapan
B.Pharm. Chiang Mai University (1979)
M.Sc. (Microbiology) Chulalongkorn
University (1986)
Appendices 7.30
4. Dr.Sunee
Techaarpornkul
B.Pharm. Chinang Mai (1984)
M.Sc. (Microbiology) Chulalongkorn
University (1989)
Ph.D. (Molecular Virology) (2001)
Appendices 5.13
5. Assoc.Prof.Dr.Nusara
Piyapolrungroj
B.Sc.in Pharm. Chulalongkorn University (1986)
M.Sc. (Food Chemistry)
Chulalongkorn University (1990)
Ph.D. (Pharmaceutics) University of
Michigan, USA. (1998)
Appendices 7.23
6. Asst.Prof.Dr.Verayuth
Lertnattee
B.Sc. in Pharm. Chulalongkorn University (1989)
M.Sc. in Pharm. Mahidol University (1991)
M.Sc.(Computer Sciences)
Chulalongkorn University (1996)
Ph.D. (Information Technology) Thammasat
University (2004)
- -
7. Asst.Prof.Dr.Auayporn
Apirakaramwong
B.Pharm. Chiang Mai (1990)
M.Sc. in Pharm Mahidol University(1992)
Ph.D. (Clinical Biochemistry)
Chiba University, Japan. (1999)
Appendices 8.57
8. Asst.Prof.Paranee
Meetam
B.S.(Pharm) Mahidol University (1990)
M.Sc.Physiology) Mahidol University (1992)
Continuing
for Ph.D.
7.43
Faculty staff
53
Name Qualification Research
Experience
Work load
For this program
(hours/week)
9. Mr.Tosak
Intaraphairot
B.Pharm. Silpakorn University (2534) Continuing for
Ph.D.
Continuing for
Ph.D.
10. Mr.Chatchai
Powthongchin
B.Sc. in Pharm. Chulalongkorn University
(2528)
M.Sc.in Pharm. (Physiology)
Chulalongkorn University (2536)
Appendices 13.47
11. Dr.Wisit
Tangkeangsirisin
◌B.Pharm. Silpakorn University (2537)
Ph.D. (Pharm Sci) Maryland, USA
(2004)
- -
12. Dr.Siripan
Limsirichaikul
B.Pharm. Khonkhaen University (2535)
M.Sc.in Pharm. Mahidol University (2538)
Ph.D. (Biochemistry)
Chiba University, Japan (2004)
- -
13. Asst.Prof.Busaba
Powthongchin
B.Pharm. Chiang Mai University, (2531)
M.Sc.in Pharm. (Pharmaceutics)
Chulalongkorn University (2536)
Continuing for
Ph.D.
Continuing for
Ph.D.
14. Dr. Suang
Rungpragayphan
B.Pharm. Silpakorn University (2537)
Ph.D. (Biochemistry)
Chiba University, Japan (2004)
- -
15. Ms. Juree
Charenteeraboon
B.Pharm. Silpakorn University (2534)
M.Sc. (Biochemistry) Mahidol University (2544)
Continuing for
Ph.D.
Continuing for
Ph.D.
16. Dr.Sarawut
Nukoolkarn
B.S. (Pharm) Mahidol University (2539)
Ph.D. (Clinical Biochemistry), Mahidol
University (2004)
Continuing for
Ph.D.
Continuing for
Ph.D.
17. Mr. Perayot
Pamornsinlapatham
B.Pharm. Naresuan University (2541) Continuing for
Ph.D.
Continuing for
Ph.D.
18. Mr. Ratpan Ramoon B.Pharm. Silpakorn University (2544)
- -
54
Name Qualification Research
Experience
Work load
For this program
(hours/week)
19. Asst.Prof.Dr.Manat
Pongchaidecha
B.Pharm. Chiang Mai University (1996)
M. Sc (Clinical Pharmacy) University of
Strathchyde UK(1989)
Ph.D. (Pharmacy) University of
Manchester , UK. (1993)
Appendices 13.45
20. Asst.Prof. Dr.Nalinee
Poolsup
B.S. (Pharm) Mahidol University (1991)
M.Sc. in Pharm. Mahidol University1993
Ph.D. (Evidence base
erapyPharmacoth ) Aston University, UK.
(2000)
Appendices 9.95
21. Asst.Porf.Dr.Watcharee
Leurmarnkul
B.Pharm. Chiang Mai University (1991)
Ph.D.(Clinical Pharmacy)
University of Wales, Cardiff, UK. (1998)
Appendices 6.16
22. Ms.Intira
Kanchanaphibool
B.Sc. in Pharm. Chulalongkorn University
(1989)
M.Sc. (Hospital and Clinical Pharmacy)
Chulalongkorn University (1998)
Continuing for
Ph.D.
Continuing for
Ph.D.
23. Ms.Surassawadee
Suntharasaj
B.Sc. in Pharm. Chulalongkorn University
(1988)
M. cS .in Pharm. Chulalongkorn University
(1993)
Continuing for
Ph.D.
Continuing for
Ph.D.
24. Dr. Monrudee
Sukma
B.Pharm. Chiang Mai University (1994)
M.Sc. Mahidol University (1996)
Ph.D. (Pharmacology) Toyama , Japan
2003
- -
25. Ms. Juntarutsamon
Dansirikul
B.Pharm. Chiang Mai University (1994)
M.Sc. Chiang Mai University (1996)
Continuing for
Ph.D.
Continuing for
Ph.D.
26. Ms. Karunrat
Tewthanom
B.Pharm. Silpakorn University (1996)
M.Sc.in Pharm. Mahidol University
(1998)
Continuing for
Ph.D.
Continuing for
Ph.D.
55
Name Qualification Research
Experience
Work load
For this program
(hours/week)
27. Ms. Nunthalukna
Sthapornnanon
B.Sc. in Pharm. Chulalongkorn University
(1987)
M.Sc. (Hospital and Clinical Pharmacy)
rsityChulalongkorn Unive (1993)
Continuing for
Ph.D.
10.72
28. Asst.Prof.Dr.Numfon
Sivanawin
B.Pharm. Silpakorn University (1997)
Pharm.D. University of IIIinois at
Chicago, USA. (1999)
Board Certified Pharmacotherapy
Specialist (BCPS) (2000)
ceCertified Pharmacy Practi
Resident. (2000)
Appendices 9.91
29. Ms.Wilai
Trakoonosot
B.Pharm. Silpakorn University (2000) Continuing for
Ph.D.
Continuing for
Ph.D.
30. Assoc.Prof.Rapeepan
Chalongsuk
B.Sc. in Pharm. Chulalongkorn University
(1979)
B.Sc. hamhang Universityin Laws Ramk
(1984)
M.Sc.in Pharm. Chulalongkorn University
(1988) MBA (1993)
Appendices 9.07
31. Asst.Prof.Danita
Phanucharas
B.Sc. in Pharm. Chulalongkorn University
(1984)
M.Sc.in Pharm. Chulalongkorn
University (1987)
Appendices 10.11
32. Ms.Yauwalak
Amrumpai
B.Sc. in Pharm. Chulalongkorn University
(1986)
M.Sc. Mahidol University (1995)
Continuing for
Ph.D.
Continuing for
Ph.D.
33. Dr.Pagamas
Maitreemit
B.Sc. in Pharm. Chulalongkorn University
(1978)
M.Sc. Mahidol University (1992)
Ph.D. Mahidol University (2000)
Appendices 8.15
56
Name Qualification Research
Experience
Work load
For this program
(hours/week)
34. Ms.Nattiya Kapol
B.Pharm. Silpakorn University (1993)
M.Sc.in Pharm. Mahidol University
(1997)
r Continuing fo
Ph.D.
8.39
35. Dr.Burin T.Sriwong
B.Pharm. Silpakorn University (1994)
M.S.,Ph.D.University of Wisconsin ,
USA) .2002(
Appendices -
36. Ms.Waranee
Bunchaycher
B.Pharm. Silpakorn University (2001) Continuing for
Ph.D.
4.63
37. Ms.Numfon
Sribundit
B.Pharm. Silpakorn University (1994)
MBA. Tumsart University (2000)
Appendices 5.35
38. Mr.Panoopat
Poompruek
B.Pharm. Silpakorn University (2001) Continuing for
Ph.D.
Continuing for
Ph.D.
39. Mr.Surasit
Rojitaumnay
B. mPhar . Silpakorn University (2001) Continuing for
Ph.D.
Continuing for
Ph.D.
40. Asst.Prof.Pensri
Nuengsigkapian
B.Sc. in Pharm. Chulalongkorn University
(1978)
M.S. (Radiopharmacy) University of
Southern California, USA. (1981)
Appendices 7.67
41. Asst.Prof.Dr.Onooma
Poobrasert
B.S.(Pharm) Mahidol University (1986)
M.Sc.in Pharm. (Pharmaceutics)
Chulalongkorn University (1988)
Ph.D. (Pharmacognosy) University of
Illinois at Chicago, USA. (1997)
Appendices 6.60
42. Assoc.Prof.Lawan
Sriphong
B.Sc. in Pharm. Chulalongkorn University
(1986)
M.Sc.in Pharm. (Pharmaceutical
Chemistry) Chulalongkorn University
(1990)
MBA. Thummasart University (1994)
Appendices 8.73
57
Name Qualification Research
Experience
Work load
For this program
(hours/week)
43. Mr.Panjapol
Laopoonpat
B.S. (Pharm) Mahidol University
(1990)
Appendices 7.53
44. Asst.Prof.Dr.Panadda
Yaipakdee
B.Pharm. Silpakorn University (1991)
Ph.D. Ohio State University USA.
(1998)
Appendices 7.63
45. Dr.Sathit Niratisai B.Sc. in Pharm. Chulalongkorn
University (1991)
M.Sc.in Pharm.Chulalongkorn
University (1994)
Ph.D. Minnesota, USA (2004)
- -
46. Dr.Kanawan
Pochanakom
B.Pharm. Chiang Mai University
(1988)
M.Sc.in Pharm. (Pharmaceutical
Chemistry) Chulalongkorn University
(1991)
Dr.rer.Nat. (Pharmaceutical
Chemistry) Bonn, Germany (1999)
Appendices 7.82
47. Asst.Prof.Dr.Chutima
Limmatvapirat
B.Pharm. Silpakorn University (1991)
Ph. D).Pharmaceutical Chemisty (
Chulalongkorn University )2000(
Appendices 8.60
48. Dr.Chanokporn
Sukonpan
B.Pharm. Chiang Mai University
(1988)
M.Sc.in Pharm. Chulalongkorn
University (1992)
Ph.D. University of Wisconsin, USA.
(2002)
- -
49. Asst.Prof.Jankana
Buranaosot
B.Pharm. Chiang Mai University
(1988)
M.Sc.in Pharm. ( aceutical Pharm
Chemistry) Chulalongkorn University
(1993)
Appendices 8.40
58
Name Qualification Research
Experience
Work load
For this program
(hours/week)
50. Asst.Prof.Malai
Satirapun
B.Sc. in Pharm. Chulalongkorn
University (1987)
M.Sc.in Pharm. ( rmaceutical Pha
Chemistry) Chulalongkorn University
(1992)
Appendices 8.20
51. Dr.Amornrut
Chaidedgumjorn
B.Pharm. Silpakorn University (1994)
Ph.D. Chiba University (2001)
Appendices -
52. Mr.Theerasak
Rojanarata
B.Pharm. Silpakorn University ( 5199 ) Continuing for
Ph.D.
Continuing for
Ph.D.
53. Mr.Paibool
Nuntanakorn
B.Sc. in Pharm. Chulalongkorn
University (1992)
M.Sc.in Pharm. Chulalongkorn
University (1996)
Continuing for
Ph.D.
Continuing for
Ph.D.
54. Mr.Kanong
Ruttanakorn
B.Pharm. Naresuan University (2002) - -
55. Dr.Vichien
Leelasagnaluk
B.Sc. in Pharm. Chulalongkorn
University (1981)
M.Sc.in Pharm. Mahidol University
(1984)
Ph.D. Chulalongkorn University (1996)
Appendices 7.27
56. Assoc.Prof.Srisombut
Nawanopparatsakul
B.Pharm. Chiang Mai University
(1987)
M.Sc.in Pharm. Chiang Mai University
(1990)
Appendices 6.41
57. Asst.Prof.Chatchai
Chinpaisal
B.Sc. in Pharm. Chulalongkorn
University (1990)
Ph.D. (Pharmacology) University of
Minnesota, USA. (1999)
cesAppendi 7.63
58. Ms.Noparat
Nattaratanapong
B.Pharm. Silpakorn University (1993)
M.Sc. (Pharmacology) Mahidol
University (1996)
Continuing for
Ph.D.
Continuing for
Ph.D.
59
Name Qualification Research
Experience
Work load
For this program
(hours/week)
59. Dr.Suravut
Watana
B.Sc. in Pharm. Chulalongkorn
University (1988)
M.Sc.in Pharm.Chulalongkorn
University (1992)
Ph.D. University of Wisconsin , USA.
(2003)
- -
60. Mr.Sarayut
Janmahasatian
B.Pharm. Chiang Mai University
(1991)
r Continuing fo
Ph.D.
Continuing for
Ph.D.
61. Dr.Patamawan
Phuagphong
B.Pharm. Chiang Mai University
(1996)
Ph.D. Osaka, Japan (2004)
- -
62. Ms.Nushjira
Pongnimitprasert
B.Pharm. Chiang Mai University (1990)
M.Sc.in Pharm.Chulalongkorn
University (1998)
tinuing for Con
Ph.D.
Continuing for
Ph.D.
63. Ms.Waraporn
Sakasawatmakhin
B.Pharm. Silpakorn University (1995) Continuing for
Ph.D.
Continuing for
Ph.D.
64.Asst.Prof.Dr.Wandee
Yanpaisan
B.Pharm. Chiang Mai University
(1983)
M.Sc. tyMahidol Universi (1987)
Ph.D.(Biotechnology) University of
New South Wales, Australia (1997)
Appendices 8.33
65. Asst.Prof.Dr.Uthai
Sotanaphun
B.Sc. in Pharm. Chulalongkorn
University (1988)
M.Sc.in Pharm. (Pharmaceutical
Botany)
Chulalongkorn University (1990)
Ph.D )Pharmaceutical Chemistry and
Natural Products (Chulalongkorn
University )1997(
Appendices 12.43
60
Name Qualification Research
Experience
Work load
For this program
(hours/week)
66. Asst.Prof.Sinthop
Chomya
B.Sc. in Pharm. n Chulalongkor
University (1980)
M.Sc.in Pharm. (Pharmaceutical
Botany)
Chulalongkorn University (1984)
Appendices -
67. Ms.Nudchanart
Kitcharoen
B.Sc. in Pharm. Chulalongkorn
University (1987)
M.Sc.in Pharm. Chulalongkorn
University (1993)
Appendices 9.5
68. Dr.Penpun
Wetwitayaklung
B.S.(Pharm) Mahidol University
(1992)
M.Sc.in Pharm. (Pharm. Chem.)
Chulalongkorn University (1995)
Ph.D. University of Vienna , Austria.
(2001)
Appendices -
69. Dr.Chavalit
Sittisombut
B. Pharm .Chiang Mai University
)1980(
M.Sc.in Pharm. Chiang Mai University
(1989)
Ph.D. (Pharmacognosy) University of
Paris V, France (2003)
- -
70. Ms.Hataiporn
Sirinamarattana
B.Pharm. Silpakorn University (2001) Continuing for
Ph.D.
Continuing for
Ph.D.
71. Ms.Tasmaporn
Sukwattanasinitti
B.Pharm. Silpakorn University (2001) Continuing for
Ph.D.
Continuing for
Ph.D.
72.Assoc.Prof.Dr.
Jurairat Nanthanid
B.S.(Pharm) Mahidol University
(1980)
M.Sc.in Pharm. Chulalongkorn
University (1986)
Ph.D. (Pharmaceutics) Mahidol
iversityUn (2000)
Appendices 11.20
61
Name Qualification Research
Experience
Work load
For this program
(hours/week)
73. Asst.Prof.Dr.
Wanchai Sutananta
B.S.(Pharm) Mahidol University
(1983)
M.Sc.in Pharm. Mahidol University
(1986)
Ph.D. ( al TechnologyPharmaceutic )
University of London , UK. (1992)
Appendices 2.80
74. Asst.Prof.Dr.
Suwannee
Panomsuk
B.Pharm. Chiang Mai University
(1987)
M.Sc.in Pharm. Chulalongkorn
University (1989)
Ph.D.( Pharmaceutics ( Toyama
Medical and Pharmaceutical
University ,Japan )1996 (
Appendices 9.67
75. Assoc.Prof.Dr.Manee
Laungtana-anan
B.Pharm. Chiang Mai University
(1983)
M.Phil, Ph.D. Manchester, UK (1989)
Appendices 11.37
76. Asst.Prof.Dr.Sontaya
Limmatvapirat
B.S.(Pharm) Mahidol University
( 8919 )
M.Sc.in Pharm. Chulalongkorn
University (1991)
Ph.D.(Pharmaceutical Technology)
Chiba University , Japan (1998)
Appendices 10.67
77. Dr.Parichat Chomto B.S.(Pharm) Mahidol University(1990)
M.Sc.in Pharm. Chulalongkorn
University (1992)
Ph. orn UniversityD Chulalongk (2000)
Appendices 5.07
78. Dr.Nutwat Nutpoolwat B.Pharm. Silpakorn University (1992)
M.Sc.in Pharm. Mahidol University
(1995)
Ph.D.(Pharmaceutics) Mahidol
University (2001)
Appendices 6.87
62
Name Qualification Research
Experience
adWork lo
For this program
(hours/week)
79. Asst.Prof.Dr.Pornsak
Sriamornsak
B.S.(Pharm) Mahidol University
(1994)
M.Sc.in Pharm. Mahidol University
(1996)
Ph.D. (Pharmaceutics) Charles Sturt
University, Australia ) 2002(
Appendices -
80. Asst.Prof.Dr.Somluk
Kongmuang
B.Sc. in Pharm. Chulalongkorn
University (1988)
M.Sc.in Pharm. Chulalongkorn
University (1991)
Ph.D.(Pharmaceutics) Purdue
University , USA. (1999)
Appendices 10.00
81. Dr.Panida
Asavapichayont
B.Sc. in Pharm. Chulalongkorn
tyUniversi (1984)
M.Sc.in Pharm. Chulalongkorn
University (1987)
Ph.D. (Pharmacy) University of
Saskatchewan, Canada. (2000)
Appendices 4.65
82. Asst.Prof.Dr.
Gaysorn Chansiri
B.Sc. in Pharm. Chulalongkorn
University(1986)
M.Sc.in Pharm. (Pharmaceutics)
lalongkorn UniversityChu (1988)
Ph.D.(Pharmaceutics) Purdue
University , USA. (1997)
Appendices 10.73
83. Asst.Prof.Dr.
Thawatchai
Phaechamud
B.Pharm. Silpakorn University (1991)
M.Sc.in Pharm. Chulalongkorn
University (1995)
Ph.D. (Pharmaceutics) Chulalongkorn
University (1999)
Appendices 10.40
63
Name Qualification Research
Experience
Work load
For this program
(hours/week)
84. Asst.Prof.Dr.
Thanasait
Ngawhirunpat
B.S.(Pharm) Mahidol University
(1993)
M.Sc. in Pharm. idol UniversityMah
(1995)
Ph.D.(Pharmaceutical Sciences)
Toyama Medical and Pharmaceutical
University, Japan (2002)
Appendices -
85. Ms.Vipaluk
Patomchaiviwat
B.S.(Pharm) Mahidol University
(1990)
M.Sc.in Pharm. Chulalongkorn
University (1993)
ng for Continui
Ph.D.
Continuing for
Ph.D.
86. Asst.Prof.Prasert
Akkaramongkolporn
B.Pharm. Silpakorn University (1992)
M.Sc.in Pharm. Mahidol University
(1995)
Continuing for
Ph.D.
Continuing for
Ph.D.
87. Asst.Prof.Dr.
Praneet Opanasopit
B.Pharm. pakorn UniversitySil (1992)
M.Sc.in Pharm. Chulalongkorn
University (1995)
Ph.D.(Pharmaceutics Sciences)
Kyoto University , Japan (2002)
- -
88. Mr.Chalermphon
Wanawongthai
B.Pharm. Silpakorn University (2001) Continuing for
Ph.D.
4.64
89. Dr.Suchda
Wanchana
B.S.(Pharm) Mahidol University
(1994)
M.Sc.in Pharm. Mahidol University
(1998)
Ph.D.(Pharmaceutical Sciences)
Toyama Medical and Pharmaceutical
University, Japan (2002)
- -
63
Research Experiences
Assoc.Prof.Dr.Sindchai Keokitichai
Research
1. Wrigglesworth, JM;Keokitchai, S;Wooster,MS & Millar, FA "Modificatrtion of
Glyceraldehyde-3-phosphate Dehydrogenase Actiivty by adsorption to
Erythorcyte Membrane and Phospholipid vesicles "563 rd Biochem. Soc.
Meeting, London, UK Vol 4:637-640 (1976)
2. Keokitichai, S & Wrigglesworth, JM "Association of Glyceraldehyde-3 -
phosphate dehydrogenase with the Membrane of the intact Erythrocyte" XI th
International Congress of Biochemistry, IUB, Toronto. Canada. (1979)
3. Keokitichai, S & Wrigglesworth, JM "Association of Glyceraldehyde-3-
phosphate dehydroenase with the Membrane of the Inteact Human Erythrocyte
"Biochem, J. 187-841 (1980)
4. Chen, SM, Keokitichai S & Wrigglesworth JM "Association of Glycolytic
Enzymes with the Erythrocyte Membrane" 592 nd Biochem. Soc. Meeting,
London, UK page 139-140 (1981)
Prof.Dr.Vira Kasantikul
Research
1. Srikiatkhachon A, Anantasethakul T, Phansuwan-Pujito P, Pathumraj
S,Kasantikul V. Effect of serotonin depletion in nitric oxide induced
cerebrovascular nociceptive response. Neuro-Report 2001; 12: 967-971.
2. Achavanuntakul B, Eiam-Ong S, Tantawichien T, Nualboonma P, Kasantikul V.
Exchange transfusion in severe falciparum malaria: a simple method modified
from hemodialysis circuit. J Med Assoc Thai 2001;84:314-322.
3. Kasantikul V. Motorcycle accident causation and identification of
countermeasure in Thailand. Vol. 1 : Bangkok study, 2001, 322 pp
4. Kasantikul V. Motorcycle accident causation and identification of
Countermeasure in Thailand. Vol. II : Upcountry study, 2001, 309 pp.
5. Piyavisetpat N, Pantongrag-Brown L, Kasantikul V. CT features of adult ilms’
tumor: a case report. Chula Med J 2002; 46: 65 – 71.
Mr.Perayot Pamornsinlapatham
Research
1. Quan, C.P., Watanabe, S., Pamonsinlapatham, P., Bouvet, J.P. (2001). Different
dysregulations of the natural antibody repertoire in treated and untreated HIV-1
patients. Journal of Autoimmunity :(in press).
64
Assoc.Prof.Dr. Nusara Piyapolungroj
Research
H. A. Apirakaramwong, and N. Piyapolrungroj (2002): Effect of antimicrobial supplement on
drug transport across Caco-2 monolayer (in Thai). Srinakharinwirot Journal of
Pharmaceutical Sciences 7:30-40.
I. N. Piyapolrungroj, and V. Leelasangaluk (2002): Effect of H2-antagonists on Paracellular
Drug Absorption. The Thai Journal of Pharmaceutical Sciences 26:45-51
J. A. Apirakaramwong, and N. Piyapolrungroj (2002): Effect of Antimicrobial Supplement on
Caco-2 Cells. The Thai Journal of Pharmaceutical Sciences 26 (Suppl.):28.
K. S. Kongmuang, and N. Piyapolrungroj (2002): Effect of Solubilizer for Riboflavin on
Caco-2 Cell Monolayer Morphology. The Thai Journal of Pharmaceutical Sciences 26
(Suppl.):53.
L. N. Piyapolrungroj, C. Li, H. Bockbrader, G. Liu, and D. Fleisher (2001): Mucosal Uptake
of Gabapentin (Neurontin) vs. Pregabalin in the Small Intestine. Pharmaceutical
Research 18:1126-1130.
Dr.Sunee Techaarpornkul
Research
1. Techaarpornkul, S., Barretto, N., and Peeples, M.E. (2001). Functional analysis of
recombinant respiratory syncytial virus deletion mutants lacking the small hydrophobic and
/or attachment glycoprotein gene. J. Virol. 75(15).
Asst.Prof.Dr.Auayporn Apirakaramwong
Research
1. Raj, V.S., Tomitori, H., Yoshida, M., Apirakaramwong, A., Kashiwagi, K., Takio, K.,
Ishihama, A., and Igarashi, K. (2001). Properties of a revertant of Escherichia coli viable
in the presence of spermidine accumulation: increase in L-glycerol 3-phosphate. J.
Bacteriol. 183:4493-4498.
2. Apirakaramwong, A., Kashiwagi, K., Raj, V.S., Kasata, K,. Kakinuma, Y., Ishihama, A.,
and Igarashi, K. (1999). Involvement of ppGpp, ribosome modulation factor, and
stationary phase-specific sigma factor s in the decrease in cell viability caused by
spermidine.Biochem. Boiophys. Res. Commun. 264:643-347.
3. Apirakaramwong, A., Fukuchi, J., Kashiwagi, K., Kakinuma, Y., Ito, E., Ishihama, A., and
65
Igarashi, K. (1998). Enhancement of cell death due to decrease in Mg2+ uptake by
OmpC (cation-selective porin) deficiency in ribosome modulation factor-deficient mutant.
Biochem. Boiophys. Res. Commun. 251:482-487.
Asst.Prof.Dr.Manat Pongchaidecha
Research
1. Daley-Yates, P.T., Cal, J.C., Cockshott, A., Pongchaidecha, M., and Gilchrist, K. (1992).
Plasma protein binding of APD: role of calcium and tranferrin. Chem.-Biol. Interactions.
81:79-89.
2. Daley-Yates, P.T., Dodwell, D.J., Pongchaidecha, M., Coleman, R.E., and Howell, A.
(1991). The clearance and bioavailability of paridronate in patients with breast cancer and
bone metastases. Calcif. Tissue Int. 49:433-435.
Asst.Prof.Dr.Nalinee Poolsup
Research
1. Li Wan Po, A., Herxheimer, A., Poolsup, N., Aziz, Z. (2001). How do Cochrane reviewers
address adverse effects of drug therapy?MG Newsletter. (June):20-21.
2. Poolsup, N., Li Wan Po, A., Knight, T.L. (2000). Pharmacogenetics and
psychopharmacotherapy. J. Clin. Pharm. Ther. 25:197-220.
3. Poolsup, N., Li Wan Po, A., and de Oliveira, I.R. (2000). Systematic overviews of lithium
treatment in acute mania. J. Clin. Pharm. Ther. 25:139-156.
4. Poolsup, N., Li Won Po, A., Oye bade, F. (1999). Measuring mania: a critical appraisal of
rating scales. J. Clin. Pharm. Ther. 24:433-443.
Asst.Prof.Dr.Watcharee Leurmarnkul
Research
1. Leurmarnkul, W. (2000). Health-related quality of life questionnire development. Thai. J.
Pharm. Sci. 24(2):71-85.
2. Leurmarnku., W., and Meetam, P. (2000). Development of a quality of life questionnaire:
SF-36 (Thai Version). Thai. J. Pharm. Sci. 24(2):92-111.
Ms.Karunrat Tewthanom
Research
H. Tewthanom K., Thongnopnua P., Pitragool R., Tewthanom K., Lukanajuntachod P,
Koikul J, Jainark P. Relationship between serum and saliva theophylline level in patient
66
with respiratory tract disease: A case study at Samutsakorn hospital in Jidavijak B,
Chulavatnatol S, Montakantikul P, Tunyasansuk K. Facing Changes in Pharmacotherapy
and Pharmacy profession. 1 st ed, The asscociation of hospital pharmacist (Thailand),
Bangkok, Thailand, 2002.
I. Tewthanom K. Therapeutic Drug Monitoring of antiretroviral: differences viewpoint.
Silpakorn University Journal 2001:Vol 21;107-HIH.
J. Tewthanom K. Saliva Therapeutic Drug Monitoring; new strategy for drug monitoring.
Silpakorn University Journal 2000:Vol 19-IS;HJS-KI.
K. Sompubut J., Sangpoum P., Tongplub R., Tewthanom K., Pongchaidacha M. Chaipak
V., Prukpakpoom A, Pitragool W. Monitoring of patient's serum theophylline level: case
study at Samutsakorn hospital in Chulavatnatol S,Suthisrisang C. Evidence-based
medicine for pharmacists. 1 st ed, The asscociation of hospital pharmacist (Thailand),
Bangkok, Thailand, 2000.
L. Sompubut J., Sangpoum P., Tongplub R., Tewthanom K., Pongchaidacha M. Chaipak
V., Prukpakpoom A, Pitragool W. Monitoring of patient's serum theophylline level: case
study at Samutsakorn hospital. Thailand regional and general hospital society
ISSS;U(HS):HS-HK.
Asst.Prof.Dr.Onooma Poobrasert
Research
1. Chantasitiporn, J., Chumchit, C., Tanamatayarat, P., Wongtieng, W., Yaipakdee, P., and
Poobrasert, O. (2000). Biological activity of plant extracts from Thai traditional
medical text for cancer therapy. J. Multidisciplinary Res. 13:24-28.
2. Poobrasert, O. (1999). Physostigmine: A revisit. Silpakorn Univ. J. 18:116-128.
3. Poobrasert, O., Constant, H.L., Beecher, C.W.W., Farnsworth, N.R., Kinghorn, A.D.,
Pezzuto, J.M., Cordell, G.A., Santisuk, T., and Reutrakul, V. (1998). Zanthones from the
twigs of Mammae siamensis. Phytochemistry 47:1661-1663.
4. Poobrasert, O., Cordell, G.A., and Bobzin, S.C. (1997). Blue degredation products of
rubreserine. J. Nat. Prod. 60:578-580.
5. Shao, Y., Ho, C.-T., Chin, C.-K., Poobrasert, O., Yang, S.-W., and Cordell, G.A. (1997).
Asterlingulatosides C and D, cytotoxic triterpenoid saponins from Aster Lingulatus. J. Nat.
Prod. 60:743-746.
67
Assoc.Prof. Lawan Sriphong
Research
1. Grobuschek, N., Sriphong, L., Schmid, M. G., Lorand, T., Aboul-Enein, H. Y. and Gubitz,
G. (2002) Chiral separation of bioactive cyclic Mannich ketones by HPLC and CE using
cellulose derivatives and cyclodextrins as chiral selectors, J. Biochem. Biophys. Methods
53:25-36.
2. Sriphong, L. (2002) Topical drugs : Computer-assisted instruction in pharmaceutical
chemistry course, Proceeding in the 19th Asian Congress of Pharmaceutical Sciences of
the Federal of Asian Pharmaceutical Associations, 5-8 October 2002.
3. Sriphong, L., Limsirichaikul, S., Wetwitayaklung, P., and Sotanaphun, U. (2000). A novel
cytotoxic alkaloid from the flowers of Senna spectabillis D.C. The symposium of young
scientists of the European Phytochemistry Society: Future Trends in Phytochemistry,
Rolduc, The Netherlands 7-11 May 2000.
4. Sriphong, L., Shik, K.Y., Toida, T., and Imanari, T. (2000). Isolation and characterization
of acharan sulfate from the giant snail Achatina fulica. The JSPS-NRCT fifth joint seminar:
Natural Medicine, Chulalongkorn University, Bangkok, Thailand, 15-17 November 2000.
5. Sriphong, L., Burana-Osott, J., Toida, T. and Imanari, T. (1999). Establishment of
disaccharide analysis from fully N-acetyled heparin and heparin sulfate. The Japaneses
Pharmaceutical Sciences Meeting, Tokushima, Japan, 27-31 March.
Asst.Prof.Dr.Panadda Yaipakdee
Research
1. Yaipakdee, P. and Robertson, L.W. (2001). Enzymatic halogenation of flavanones and
flavones. Phytochemistry 57(3):341-347.
2. Chantasitiporn, J., Chumchit, C., Tanamatayarat, P., Wongtieng, W., Yaipakdee, P., and
Poobrasert, O. (2000/2001). Biological activity of plant extracts from Thai traditional text
for cancer therapy. Journal of Multidisciplinary Research 13:24-28.
3. Yaipakdee, P. (2000). Application of combinatorial synthesis in drug discovery process.
Thai J. Pharm. Sci. 24(3-4):121-142.
4. Yaipakdee, P. (2000). Drug discovery from microorganisms. Silpakorn University Journal
19-20(2):70-94.
5. Yaipakdee, P. (1998). Cyclic peptides: a new target for antifungal therapy. Silpakorn
University Journal 18(1):156-166.
68
Asst.Prof.Dr.Chutima Limmatvapirat
Research
1. Jaruchoktaweechai, C., Suwanborirux, K., Tanasupawat, S., Kittakoop, P., and
Menasresta, P. (2000). New macrolactins from a marine Bacillus sp. Sc026. J. Nat. Prod.
63:984-986.
Asst.Prof.Jankana Buranaosot
Research
1. Burana-osot, J and Buchbauer, J., Determination of volatile compounds from Hoya
carnosa, (L.f.) R.Br. (Asclepiadaceae) flowers. Thai J. Pharm. Sci. 26 (1-2): 39-44 (2002).
2. Burana-osot, J. and Yanpaisan, W. (2002) Simple and simultaneous determination of
individual catechins and xanthines in green tea. Proceeding of the 19th Congress of
FAPA, Seminar on Asian Congress of Pharmaceutical Science and Practice, 5-8 October,
Seoul, Korea.
Dr.Amornrut Chaidedgumjorn
Research
1. Chaidedgumjorn A, Suzuki A, Toyoda H, Toida T, Imanari T, Linhardt RJ. Conductivity
detection for molecular mass estimation of per-O-sulfonated glycosaminoglycans
separated by high-performance size-exclusion chromatography. J Chromatogr A. 2002;
2. Chaidedgumjorn A, Toyoda H, Woo ER, Lee KB, Kim YS, Toida T, Imanari T. Effect of
(1 3)-and (1 4)-linkages of fully sulfated polysaccharides on their anticoagulant
activity Carbohydr Res. 2002;337 (01):925-33.
3. Sudo M, Sato K, Chaidedgumjorn A, Toyoda H, Toida T, Imanari T. 1H nuclear magnetic
resonance spectroscopic analysis for determination of glucuronic and iduronic acids in
dermatan sulfate, heparin, and heparan sulfate. Anal Biochem. 2001;297(1):42-51.
4. Toida T, Suzuki A, Nakajima K, Chaidedgumjorn A, Imanari T. Effect of 6-O-sulfonate
hexosamine residue on anticoagulant activity of fully O-sulfonated
5. Chaidedgumjorn A, Todida T, Imanari T,Woo ER,Park H, Linhardt RJ, Woo SJ and Kim
YS. A new sulfated beta-galactan from clams with anti-HIV activity. Carbohydr Res,
1999;337(10):925-33.
69
Asst.Prof.Chatchai Chinpaisal
Research
1. Wei, L-N., Hu, X., and Chinpaisal, C. (2000). Constitutive activation of retinoic acid
receptor beta2 promoter by orphan nuclear receptor TR2. J. Biol. Chem. 27(16):11907-
11914.
2. Lee C.H., Chinpaisal, C. and Wei, L.N. (1998). A novel nuclear receptor
heterodimerization pathway mediated by orphan receptors TR2 and TR4. J. Biol. Chem.
273(39):25209-25215.
3. Chinpaisal C., Lee, C.H., and Wei, L.N. (1998). Mechanisms of the mouse orphan nuclear
receptor TR2-11-medicated gene suppression. J. Biol. Chem. 273(29):18077-18085.
4. Yu, Z., Lee, C.H., Chinpaisal, C., and Wei, L.N. (1998). A constitutive nuclear localization
signal from the second zinc-finger of orphan nuclear receptor TR2. J. Endocrinol.
159(1):53-60.
5. Lee, C.H., Chinpaisal, C., and Wei, L.N. (1998). Cloning and characterization of mouse
RIP140, a corepressor for nuclear orphan receptor TR2. Mol. Cell. Biol. 18(11):6745-
6755.
Asst.Prof.Dr.Wandee Yanpaisan
Research
1. Yanpaisan, W., King, N.J.C., and Doran, P.M. (1999). Flow cytometry of plant cells with
applications in large-scale bioprocessing. Biotechnology Advances 17:3-27.
2. Yanpaisan, W., King, N.J.C., and Doran, P.M. (1998). Analysis of cell cycle activity and
population dynamics in heterogeneous plant cell suspension using flow cytometry. Journal
of Biotechnology and Bioengineering 58:515-528.
3. Yanpaisan W. (1989). The effect of phytohormones and some additives on tissue culture
establishment and in vitro production of alkaloids from Arcangelsa flava Merr. Journal of
the National Research Council of Thailand 21(1).
4. Yanpaisan, W., King, N.J.C., and Doran, P.M. (1997). Flow cytometry analysis of cell
cycle activity and population dynamics in suspended plant cell culture. American Institute
of Chemiscal Engineers 1997 Annual Meeting, Los Angeles, CA, 16-21 November.
70
Dr.Penpun Wetwitayaklung
Research
1. Wissenschaftliche Tagung der Osterreichischen Pharmazeutischen Gesellschaft, 30
September –2 October 1999, In Innsbruck.” P.Wetwitayaklung, G.Ecker and
W.Fleischhacker
2. XVIth International Symposium on Medicinal Chemistry, 18-22 September 2000, In
Bologna, Italy. “Synthesis and MDR-Modulating Activity of Enantiopure 1-
Benzopyrano[3,4-b][1,4]oxazines” P.Wetwitayaklung, P.Chiba and G.Ecker
3. 222nd American Chemical Society National Meeting, 26-30 August 2001, In Chicago.
Illinois. “A Hologram QSAR analysis of Benzopyrane-type Modulators of Multidrug
Resistance” P.Wetwitayaklung, D.Kaiser, P.Chiba and G.Ecker
4. 16th Scientific Congress of the Austrian Pharmaceutical Society to gether with 4th Central
European Symposium on Pharmaceutical Technology, 23-25 September 2001, In Vienna,
Austria. “Synthesis and MDR Modulating Activity of Enantiopure Benzopyrano[3,4-
b][1,4]oxazines” P.Wetwitayaklung, S.Kopp, P.Chiba and G.Ecker
Asst.Prof.Dr.Uthai Sotanaphun
Research
1. Ngamkham, J., Ondee, S., Sotanaphun, U., Sittisombut, C. and Picha, P. (2001). Cytotoxicity of
leaf extracts of Plu, Piper betle on cultured mammalian neoplastic cells. 16th Asian-Pacific
cancer congress 2001. Manila, Philippine, 18-21 Nov.
2. Sotanaphun, U., Lipipun, V. and Bavovada, R. (2001). Phenolic-(9→8)-D:A-friedo-24-
noroleananes : A new class of antiviral agents. Pharma Indochina II, Hanoi, Vietnam, 20-23
Oct.
3. Bavovada, R., Chavalittumrong, P., Pingsuthiwong, C., Sotanaphun, U., Sukhakul, T.,
Thongphasuk, P. and Thanakijcharoenpath, W. Chemical and ethnobotanical in vestigation of
Thai Strychnos species. NRCT-JSPS core university system on pharmaceutical sciences. The
fifth joint seminar : Natural medicines. Bangkok, Thailand, 15-17 Nov.
4. Sripong, L., Sotanaphun, U., Vajvittayaklung, P. and Limsirichaikul, S. (2000). The alkaloids
from the flower of Cassia spectabilis D.C. and their cytotoxic activity. The symposium of young
scientists of the European Phytochemistry Society : Future trends in phytochemistry. Rolduc,
Natherlands, 7-11 May.
5. Sotanaphun, U., Suttisri, R., Lipipun, V. and Bavovada, R. (2000). A new 3,4-seco-ursane
triterpenoid from Glyptopetalum sclerocarpum. Chem. Pharm. Bull. 48(9), 1347-1349.
71
Asst.Prof.Wanchai Sutananta
Research
1. Sutananta, W., Craig, D.Q.M., and Newton, J.M. (1996). The use of low frequency
dielectric spectroscopy as a means of characterising the effects of moisture uptake by
pharmaceutical glyceride bases. Int. J. Pharm. 132:1-8.
2. Sutananta, W., Craig, D.Q.M., and Newton, J.M. (1995). The use of low frequency
dielectric spectroscopy as a novel means of investigating the structure of pharmaceutical
glyceride bases. Int. J. Pharm. 125:123-132.
3. Sutananta, W., Craig, D.Q.M., and Newton, J.M. (1995). An evaluation of the mechanism
of drug release from glyceride bases. J. Pharm. Pharmacol. 47:182-187.
4. Sutananta, W., Craig, D.Q.M., and Newton, J.M. (1995). An Investigating into the effect of
preparation conditions and storage on the rate of drug release from pharmaceutical
glyceride bases. J. Pharm. Pharmacol. 47:355-359.
5. Sutananta, W., Craig, D.Q.M., and Newton, J.M. (1994). The investigating into the effect
of preparation conditions on the structure of pharmaceutical glycerides using differential
scanning calorimetry and polarized light microscopy. Int. J. Pharm. 110:75-91.
Asst.Prof.Dr.Suwannee Panomsuk
Research
1. Koizumi, T., Panomsuk, S.P., Hatanaka, T., and Katayama, K. (1996). Kinetics of swelling
of compressed cellulose matrices : A mathematical model. Pharm. Res. 13:329-333.
2. Panomsuk, S.P., Hatanaka, T., Aiba, T., Katayama K., and Koizumi. (1996). A study of
the hydrophilic cellulose matrix : Effect of drugs on swelling properties. Chem. Pharm.
Bull. 44:1039-1042.
3. Koizumi, T. and Panomsuk, S.P. (1995). Release of medicaments from the spherical
matrices containing drug in suspension : Theoretical aspects. Int. J. Pharm. 166:45-49.
Asst.Prof.Dr.Sontaya Limmatvapirat
Research
1. Luangtana-Anan, M. Limmatvapirat, S. Development of readily soluble and less irritate
indomethacine tablet, Silparkorn University Journal 2536;13:24-32.
2. Limmatvapirat, S. Inclusion compound formation between deoxycholic acid and guest by
grinding and sealed heating, Proceeding of the 116th Annual Meeting of Association of
Pharmacy, Japan, 1996, 17.
72
3. Limmatvapirat, S. Yonemochi, E. Oguchi, T. Yamamoto K. Complex formation between
deoxycholic acid and menadione by grinding and sealed heating method. Chem Pharm
Bull 1997;45:1358-1362.
4. Limmatvapirat, S. Inclusion compound formation between deoxycholic acid and salicylic
acid by grinding method. Yakuzaigaku 1997;57:176-177.
5. Limmatvapirat, S. Yamaguchi, K. Yonemochi, E. Oguchi, T. A 1:1 deoxycholic-salicylic
acid complex. Acta Cryst C 1997;C53:803-805.
Asst.Prof.Dr.Pornsak Sriamornsak
Research
1. Sriamornsak P, Nunthanid J, Wanchana S, and Luangtana-anan A. Composite film-
coated tablets intended for colon-specific delivery of 5-aminosalicylic acid using
desterified pectin. Pharmaceutical Development and Technology 2003; in press.
2. Nunthanid J, Wanchana S, Sriamornsak P, Limmatavapirat S, Luangtana-anan and
Puttipipatkhachorn S. Effect of heat on characteristics of chitosan film coated on
theophylline tablets. Drug Development and Industrial Pharmacy 2002; 28: 919-930.
3. Sriamornsak P. Effect of calcium concentration, hardening agent and drying condition on
release characteristics of oral proteins from calcium pectinate gel beads. European
Journal of Pharmaceutical Sciences 1999; 8(3): 221-227.
4. Sriamornsak P and Nunthanid J. Calcium pectinate gel beads for controlled release drug
delivery: II. Effect of formulation and processing variables on drug release. Journal of
Microencapsulation 1999; 16(3): 303-313.
5. Sungthongjeen S, Pitaksuteepong T, Somsiri A and Sriamornsak P. Studies on pectins as
potential controlled-release matrix tablets. Drug Development and Industrial Pharmacy
1999; 25: 1271-1276.
Asst.Prof.Dr.Somluk Kongmuang
Research
1. Kongmuang, S. (1991). Mechanism of increasing dissolution by solid dispersion
technique. Thai. J. Pharm. Sci. 16
73
Assoc.Prof.Dr.Jurairat Nanthanid
Research
1. Puttipipatkhachorn, S., Nunthanid, J., Yamamoto, K., and Peck, G.E. (2001). Drug
physical state and drug-polymer interaction on drug release from chitosan matrix films. J.
Control. Rel. 75(1-2):143-153.
2. Nunthanid, J., Puttipipatkhachorn, S., Yamamoto, K., and Peck, G.E. (2001). Physical
properties and molecular behaviors of chitosan films. Drug Dev. Ind. Pharm. 27(2):143-
157.
3. Sriamornsak, P. and Nunthanid, J. (1999). Calcium pectinate gel beads for controlled
release drug delivery: II. Effect of formulation and processing variables on drug release.
J. Microencap. 16(3):303-313.
4. Sriamornsak, P. and Nunthanid, J. (1998). Calcium pectinate gel beads for controlled
release drug delivery: I. Preparation and in-vitro release studies. Int. J. Pharm. 160:207-
212.
5. Nunthanid, J., Chalongsuk, R., and Leelasa-ngaluk, V. (1993). Study of knowledge,
attitude, and practice of people on Village-Drug-Co-Operatives in Nakornpathom province.
Silpakorn Unviersity Journal 13:35-47.
Asst.Prof.Dr.Gaysorn Chansiri
Research
1. Chansiri, G., Lyon, R.T., Patel, M.V., and Hem, S.L. (1999). Effect of Surface Charge on
the Stability of Oil/Water Emulsions during Steam Sterilization. J. Pharm. Sci. 88(4):454-
458.
2. Chansiri, G. (1998). Lipid Emulsions : A Potential Carrier for Drug Targeting to the
Reticuloendothelial System. Silpakorn University Journal 18(1):192-199.
3. Chansiri, G., Chansiri, K., Tan-ariya, P., Nokdhes, C., and Sarataphan, N. (1998). Efficacy
of Medicinal Plants as Anti-parasitic Drugs Against Theileria Sp. In In-Vitro Culture of
Infected Bovine Erythrocytes. Silpakorn University Journal 18(1):39-50.
4. Gruenhagen, S.E., Schulze, D.G., Chansiri, G., Hem, K.J., White, J.L., and Hem, S.L.
(1997) Effect of Sorbitol on the Phosphate Adsorptive Capacity of Ferrihydrite
Suspension. Pharm. Dev. Technol. 2(1):81-86.
74
Dr.Nattawat Natpoolwat
Research
1. Palanuphap S, Mitrevej A, Sinchaipanid N, Natpoolwat C. Study on deformation of direct
compression fillers using computerized technology. Presented at The Academic Annual
Meeting, The Pharmaceutical Association of Thailand under Royal Patronage, Petchaburi,
April 1995.
2. Natpoolwat C, Mitrevej A, Junyaprasert V, Sinchaipanid N, Naratikornrit N. Study of
aqueous colloidal ethylcellulose on drug release from propanolol hydrochloride pellets.
Presented at The Academic Annual Meeting, The Pharmaceutical Association of Thailand
under Royal Patronage, Petchaburi, April 1995.
3. Mitrevej A, Sinchaipanid N, Natpoolwat N, Sermsuppasuk P, Supattanawong P.
Preparation of sustained release phenylpropanolamine hydrochloride - wax matrices in
hard gelatin capsules. Asian J Pharm 1996; 16: D-17.
4. Sinchaipanid N, Mitrevej A, Natpoolwat N. Enteric film coating with methacrylic acid –
methacrylate copolymer aqueous dispersion (Eudragit L30D-55). J Ind Pharm 1997; 2(3):
70-5.
5. Mitrevej A, Sinchaipanid N, Natpoolwat N, Naratikornrit N. Design and fabrication of
multi – unit controlled release phenylpropanolamine hydrochloride capsules and tablets.
Drug Dev Ind Pharm 1998; 24(8): 793-6.
Asst.Prof.Dr.Thanasat Ngawhirunpat
Research
1. Tanasait Ngawhirunpat, Hiroshi Yoshikawa , Tomomi Hatanaka, Tamotsu Koizumi, Isao
Adachi. Age-related changes in skin permeability of hydrophilic and lipophilic compounds
in rats. Pharmazie 56 , 3, 231-234 (2001).
2. Tanasait Ngawhirunpat, Tomomi Hatanaka, Junichi Kawakami, Isao Adachi. Age
difference in simultaneous permeation and metabolism of ethyl nicotinate in rat skin. Biol.
Pharm. Bull.24 (4) 414-417 (2001).
3. Tanasait Ngawhirunpat, Hiroshi Yoshikawa , Tomomi Hatanaka, Kazunori Katayama,
Junichi Kawakami, Isao Adachi. Change in electrophysiological properties of rat skin with
age. Change in electrophysiological properties of rat skin with age. Biol. Pharm. Bull.25
(9) 1192-1196 (2002).
4. Tanasait Ngawhirunpat, Praneet Opanasopit, Korakot Chaturon, Jamaree
Leewansangthong, Suwannee Panomsuk. In vitro permeation of ketoprofen gel: Effect of
Carbopol 940 and Pluronic F-127. Silpakon J. 18 (1), 79-86 (1998)
75
Asst.Prof.Dr.Praneet Opanasopit
Research
1. Praneet Opanasopit, Keiko Shiraishi, Makiya Nishikawa, Fumiyoshi Yamashita, Yoshinobu
Takakura, and Mitsuru Hashida In vivo recognition of mannosylated proteins by hepatic
mannose receptors and mannan-binding protein. Am. J. of Physiol. Gastrointest liver
Physiol, 280, G879-G889 (2001)
2. Praneet Opanasopit, Yuriko Higuchi, Shigeru Kawakami, Fumiyoshi Yamashita, Makiya
Nishikawa, and Mitsuru Hashida Involvement of serum mannan binding proteins and
mannose receptors in uptake of mannosylated liposomes by macrophages. Biochim.
Biophys. Acta. 1511(1):134-145. (2001)
3. Praneet Opanasopit, Makiya Nishikawa, Fumiyoshi Yamashita, Yoshinobu Takakura, and
Mitsuru Hashida Pharmacokinetic analysis of Lectin-dependent biodistribution of fucosylated
bovine serum albumin: A possible carrier for kupffer cells. J. Drug Targeting, Vol 9: 341-
351 (2001)
4. Praneet Opanasopit, megumi Sakai, Makiya Nishikawa, Shigeru Kawakami, Fumiyoshi
Yamashita, and Mitsuru Hashida Inhibition of experimental liver metastasis by lectin-
mediated targeting of immunomodulators to liver nonparenchymal cells using
mannosylated liposomes. J. Controlled Release, 80 (1-3),283-294 (2002).
5. Praneet Opanasopit, Kenji Hyoudou, Makiya Nishikawa, Fumiyoshi Yamashita, and
Mitsuru Hashida Serum mannan binding protein inhibits mannosylated liposome-mediated
transfection to macrophages. Biochim. Biophys. Acta. 1570, 203-209 (2002).
Asst.Prof.Dr.Thawatchai Phaechamud
Research
1. Rittidej, G.C., Phaechamud, T., and Koizumi, T. (2001). Moist heat treatment on
physicochemical change of chitosan salt films. Int. J. Pharm. (In press)
2. Koizumi, T., Rittidej, G.C., and Phaechamud, T. (2001). Mechanistic modeling of drug
release from chitosan coated tablets. J. Control. Rel. 70:277-841.
3. Phaechamud, T., Koizumi, T., and Ritthidej, G.C. (2000). Chitosan citrate as film former:
compatibility with water-soluble anionic dyes and drug dissolution from coated tablet. Int.
J. Pharm. 198:97-111.
4. Ritthidej, G.C., Phaechamud, T., and Koizumi, T. (2000). Additives in moist-heat-treated
chitosan acetate films: a method to extend the release of propranolol hydrochloride-
coated tablets. STP. Pharma. Sci. 10(1):112-119.
5. Phaechamud, T. (1997). Colonic drug delivery: study and strategy. Thai J. Pharm. Sci.
21:7-20.
76
Dr.Panida Asavapichayont
Research
1. Asavapichayont, P. and Foldvari, M. (2000). Improved method for high performance
liquid chromatograghic analysis of tetracaine and its metabolite in human skin
homogenate. Manuscript in preparation
2. Asavapichayont, P., and Foldvari, M. (2000). Kinetic study of tetracaine hydrolysis in
human skin homogenate. Manuscript in preparation.
3. Asavapichayont, P., Naik, R., and Foldvari, M. (2000). Development of an in vitro viable
skin model for the simultaneous assessment of delivery and cutaneous metabolism of
ester drugs. Manuscript in preparation; to be submitted to the Journal of Investigative
Dermatology.
4. Asavapichayont, P. and Foldvari, M. (1998). Dermal delivery of ester type drugs: the fate
of tetracaine in human skin homogenate. Pharm. Sci. 1(1):S-373.
5. Asavapichayont, P., Hu, J. and Foldvari, M. (1997). Development of an HPLC method for
simultaneous analysis of tetracaine and its metabolite in dosage forms and biological
fluids, with comparison to capillary electrophoresis method. Pharm. Res. 14(11):S-565.
Assoc.Prof.Dr.Manee Laungtana-anan
Research
1. Luangtana-Anan, M. Limmatavapirat S, Sripong L. and Fell J.T. (1996). Physical and
chemical stability of film coated ranitidine tablets. Archives of Pharm. Res.
2. Luangtana-Anan, M. and Limmatavapirat, S. (1993). Development of readily soluble and
less Irritated indomethacin tablet. Journal of Silpakorn University 13:24-32.
3. Luangtana-Anan, M., Catellani P.L., Colombo, P., Dinarvand, R. and Fell, J.T. (1992). The
role of bond weakening by liquids in the disintegration of tablets. The European Jounal of
Pharmaceutics and Biopharmaceutics 38(5):169-171.
4. Luangtana-Anan, M. and Fell, J.T. (1990). Bonding Mechanisms in Tableting. International
Journal of Pharmaceutics 60:197-202.
5. Luangtana-Anan, M. and Fell, J.T. (1988). Surface energies of Pharmaceutical solids
before and after compaction. International Journal of Pharmaceutics 41:237-240.
77
Asst.Prof.Prasert Akkaramongkolporn
Research
1. Akkaramongkolporn P., Etsuo Y. and Terada K. (2000). Molecular state of
chlorpheniramine in resinates. Chem. Pharm. Bull. 48(2):231-234.
2. Akkaramongkolporn P. (1997). Behavior of drug loading onto cation-exchange resin by
batch multiple equilibria method. Thai J. Pharm. Sci. 21(2):99-106.
3. Akkaramongkolporn P. (1997). Kinetic of Drug Loading onto Cation-exchange Resin and
Effect of Concurrent Counter-ions. Thai J. Pharm. Sci. 21(1):33-42.
4. Akkaramongkolporn P. and Prakongpan S. (1996). Production of sustained release
dosage form using ion-exchange resin. J. Indust. Pharm. 1(1):1-9.
Dr.Surawut Watana
Research
1. Dihydroxyvitamin D-3 may stabilize osteocalcin m RNA via the predicted stem-
loop structure in the 5’-UTR. FASEB Journal,14(8):1482.(2000)
Dr.Wisit Tangkeangsirisin
Research
1. Tangkeangsirisin, W., Thientanawat, A., Brodie, A., and Serrero, G. (2000)
Adipocyte Differentiation-related Protein Reduces Aromatase Activity. School of
Pharmacy University of Maryland, Baltimore, MD, May 2000.
2. Tangkeangsirisin, W. and Serrero, G. (2001) Role of PC-cell Derived Growth
Factor in Estrogen Responsiveness and Drug Resistance in Human Breast
Cancers. 23rd Annual Graduate Research Conference, University of Maryland,
Baltimore, MD, April 2001. Cancer Biology B Session.
3. Tangkeangsirisin, W., Huifeng, D., Xufeng C. and Serrero, G. (2002) Role of
PC-cell derived Growth Factor in the Estrogen Responsiveness and Anti-
estrogen Resistance in Human Breast Cancer, 24th Annual Graduate Research
Conference, University of Maryland, Baltimore County, MD, April 2002. Cancer
Biology Session.
4. Tangkeangsirisin, W., Huifeng, D., Xufeng C. and Serrero, G. (2002) Role of
PC-Cell Derived Growth Factor in the Alteration of Estrogen Responsiveness
78
and in the Acquisition of Anti-estrogen Resistance in Human Breast Cancer,
American Association of Cancer Research 93rd Annual Meeting, San Francisco,
CA.
5. Tangkeangsirisin, W. and Serrero, G. (2003) Adipose Differentiation-related
Protein (ADRP) Induces Differentiation of Human Breast Cancer MCF-7 Cells,
American Association of Cancer Research 94th Annual Meeting, Washington,
DC.
6. Tangkeangsirisin, W. and Serrero, G. (2003, in press) Resveratrol in the
Chemoprevention and Chemotherapy of Breast Cancer, CRC Press.
7. Tangkeangsirisin, W., Hayashi, J. and Serrero, G. (2004) PC Cell-Derived
Growth Factor Mediates Tamoxifen Resistance and Promotes Tumor Growth of
Human Breast Cancer Cells. Cancer Res, 64, 1737-43.
8. Tangkeangsirisin, W. and Serrero, G. (2004, in press) PC Cell-Derived Growth
Factor (PCDGF/GP88, progranulin) Stimulates Migration, Invasiveness and
VEGF expression in Breast Cancer Cells. Carcinogenesis.
9. Tangkeangsirisin, W. and Serrero, G. (2003, on preparing) ADRP induces cell
differentiation in breast cancer.
Dr Suang Rungpragayphan
Research
1. Suang Rungpragayphan, Yasuaki Kawarasaki, Takao Imaeda, Katsunori Kohda,
Hideo Nakano, and Tsuneo Yamane. (2002) High-throughput, cloning-
independent protein library construction by combining single-molecule DNA
amplification with in vitro expression. Journal of Molecular Biology. 318, 395-
405.
2. Suang Rungpragayphan, Hideo Nakano, and Tsuneo Yamane. (2003) PCR-
linked in vitro expression: a novel system for high-throughput construction and
screening of protein libraries. FEBS Letters. 540, 147-150.
3. Suang Rungpragayphan, Megumi Haba, Hideo Nakano, and Tsuneo Yamane.
Rapid screening for affinity-improved scFvs by means of single-molecule-PCR-
linked in vitro expression. ( Journal of Molecular Catalysis B: Enzymatic, in
press)
72
รายละเอยดงบประมาณ
หลกสตรเภสชศาสตรบณทต (หลกสตรนานาชาต)
คณะเภสชศาสตร มหาวทยาลยศลปากร
1. รายรบ ตอนกศกษา 1 รน (60 คน/รน ระยะเวลารวม 10 ภาค การศกษาปกต) 1.1 รายรบสวนกลางมหาวทยาลย
- คาบารงการเปนนกศกษามหาวทยาลยศลปากร 600,000.- บาท - คาบารงและคาธรรมเนยมอ,น ๆ 798,000.- บาท
1.2 รายรบสวนของคณะเภสชศาสตร - คาหนวยกต (500,000 บาท x 60 คน ) 30,000,000.- บาท - คาธรรมเนยมพเศษ (250,000 บาท x 60 คน) 15,000,000.- บาท
รวมรายรบสาหรบการบรหารจดการและดาเนนการหลกสตร (เฉพาะคณะเภสชฯ) 45,000,000.- บาท
2. รายจาย ตอนกศกษา 1 รน (60 คน /รน ระยะเวลารวม 10 ภาคการศกษาปกต) 2.1 เงนจดสรรจากรายรบเฉพาะคาหนวยกตเขามหาวทยาลยรอยละ 6 1,800,000.- บาท 2.2 รายจายจากการบรหารจดการและดาเนนการหลกสตร(เฉพาะคณะเภสชฯ) 29,029,000.- บาท
รวมรายจาย (2.1 + 2.2 ) 30,829,000.- บาท 3. รายรบหลงหกรายจายทBงหมด 14,171,000.- บาท 4. รายจายเปนงบลงทนทางการศกษาเพ,อการพฒนาเชงรก 5,000,000.- บาท
รายละเอยดรายจายในการบรหารจดการหลกสตร
รายละเอยดของรายจายองตามเกณฑระเบยบมหาวทยาลยศลปากรวาดวยคาใชจายในการบรหารและจดการหลกสตรของมหาวทยาลยศลปากรในลกษณะโครงการพเศษ พ.ศ. 2538 และฉบบท, 2 พ.ศ. 2539 โดยประมาณการคาใชจายดงนB 1. คาตอบแทน
- คาตอบแทนอาจารยพเศษ/อาจารยของรายวชาตามหลกสตร 4,816,500.- บาท - คาตอบแทนผประสานงานรายวชา 362,500.- บาท - คาตอบแทนอาจารยในงานบรหารธรการหลกสตร 12,000,000.- บาท - คาตอบแทนเจาหนาท,ในการปฏบตงานตามโครงการ 2,400,000.- บาท - คาตอบแทนลกจางในการปฏบตงานตามโครงการ 900,000.- บาท
73
2. คาตอบแทนในลกษณะเบBยประชมตลอด 5 ป การศกษา
- สาหรบกรรมการดาเนนงานโครงการไมเกนครB งละ/คนละ 500 บาท 1,200,000.- บาท 3. คาตอบแทนผตรวจบญชอนญาต 48,000.- บาท 4. คาใชจายในการเดนทางเพ,อปฏบตหนาท,ตามหลกสตร - คาใชจายในการเดนทางของกรรมการไมเกนวงเงนปละ 250,000 บาท 1,250,000.- บาท - คาใชจายในการเดนทางของอาจารย/เจาหนาท,ไมเกนปละ 200,000 บาท 1,000,000.- บาท5. คาสาธารณปโภค 400,000.- บาท6. คาวสด/อปกรณวทยาศาสตร/สารเคม 4,452,000.- บาท7. คาใชจายอ,น ๆ 200,000.- บาท รวมคาใชจายในการบรหารจดการหลกสตร 29,029,000.- บาท
จานวนนกศกษา ณ จดคมทน = = 41.1 ~ 41 คน
ประมาณการคาใชจายตอนกศกษา 1 คน
ประมาณการคาใชจายตอนกศกษา 1 รน = 30,829,000.- บาท
ประมาณการคาใชจายตอนกศกษา 1 คน ตลอดหลกสตร = 30,829,000.- บาท = 513,817.- บาท หรอ 102,765.- บาท/ป
750,000.- บาท/คน 30,829,000.- บาท
60 คน
74
Budget
The administrative cost of the program will be supported by tuition fees and spicial fees of approximately 773,300 Baht per student for entire program. The break even cost will be couered at number of 41 students in each enrollment.
Estimated revenue and expenses
For the total of 60 students in each enrollment ,the nevenue and expenses are as the following: (1) revenue (750,000 x 60 ) 45,000,000.- Baht
1.1 tuition fee (30,000,000 Baht) 1.2 special fee (15,000,000 Baht)
(2) expenses 30,829,000.- Baht 2.1 administrative cost (1,800,000 Baht) 2.2 operational cost (29,029,000 Baht) (3) gross revenue 14,171,000.- Baht (4) investment & development cost 5,000,000.- Baht Estimated cost per each graduate 513,817.- Baht
Or 102,765.- Baht/year